Heart failure, strict

I9_HEARTFAIL

systolic heart failure: Heart failure caused by abnormal myocardial contraction during systole leading to defective cardiac emptying.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I11.0, I13.0, I13.2, I50 Hospital discharge: ICD-9 — 4029B\|428 Hospital discharge: ICD-8 — 42700\|42710\|428\|7824 Cause of death: ICD-10 — I11.0, I13.0, I13.2, I50 Cause of death: ICD-9 — 4029B\|428 Cause of death: ICD-8 — 42700\|42710\|428\|7824 KELA reimbursements: KELA codes — 201 Medicine purchases: ATC — C03CA01\|C03EB01 4 out of 7 registries used, show all original rules.	38748
4. Check minimum number of events Min. number of events 3, and need other rules	38748
5. Include endpoints None	38748
6. Filter based on genotype QC (FinnGen only)	38748

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF6

NAME	I9_HEARTFAIL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I50\|I110\|I130\|I132
HD_ICD_9	4029B\|428
HD_ICD_8	42700\|42710\|428\|7824
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I50\|I110\|I130\|I132
COD_ICD_9	4029B\|428
COD_ICD_8	42700\|42710\|428\|7824
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	201
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER	YES
KELA_ATC	C03CA01\|C03EB01
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Heart failure, strict based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	488284	258381	222422
Only index persons	306110	164935	141175
Unadjusted period prevalence (%)
Whole population	6.87	7.40	6.21
Only index persons	5.75	6.06	5.39
Median age at first event (years)
Whole population	73.72	75.74	71.47
Only index persons	74.89	77.35	72.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	38748	14883	23865
Unadjusted period prevalence (%)	8.43	5.07	10.52
Median age at first event (years)	71.34	72.03	70.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14838: Matched controls
129556

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BA02

ATC

metformin; oral

2.4

323.0

5669

26121

I48.1

ICD-10 Finland

Persistent atrial fibrillation

9.1

323.0

1066

1096

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.9

323.0

2551

6474

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

323.0

2576

7077

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.2

323.0

796

793

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

3.6

323.0

4196

12767

S97

ICPC

Chronic ulcer skin

4.7

323.0

1484

3004

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.5

323.0

7731

18571

I50.1

ICD-10 Finland

Left ventricular failure

1717.3

323.0

4022

C08CA01

ATC

amlodipine; oral

2.1

323.0

6648

36552

C09AA05

ATC

ramipril; oral

4.6

323.0

7082

21559

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.3

323.0

1125

1979

B01AF02

ATC

apixaban; oral

4.7

323.0

2937

6454

R03BB04

ATC

tiotropium bromide; inhalant

3.3

323.0

2207

6461

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

323.0

3741

12564

AA1AD

NOMESCO Finland

CT of head and brain

2.3

323.0

4436

20557

207

Kela drug reimbursment

Chronic arrhythmias

6.7

323.0

5353

10084

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.9

323.0

7270

18177

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

9.7

323.0

2659

2844

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

323.0

2159

6143

I48

ICD-10 Finland

Atrial fibrillation and flutter

7.4

323.0

7445

15557

M04AA01

ATC

allopurinol; systemic

3.7

323.0

3330

9464

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.3

323.0

1688

3743

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.9

323.0

2279

5689

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.8

323.0

1675

4233

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.6

323.0

1381

2807

TFP20

NOMESCO Finland

Cardiodefibrillation

5.9

323.0

2867

5023

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.1

323.0

2671

6547

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

274.9

323.0

1394

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

10.2

323.0

2010

1956

C03CA01

ATC

furosemide; systemic

25.3

323.0

11717

16757

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

323.0

3877

10248

H02AB06

ATC

prednisolone; systemic

2.1

323.0

7777

44059

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.0

323.0

5038

19142

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

410.1

323.0

676

A46

ICD-10 Finland

Erysipelas

3.3

323.0

3305

10421

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

360.3

323.0

824

103

Kela drug reimbursment

Diabetes, insulin-treated

2.8

323.0

5849

24449

XF404

NOMESCO Finland

Ambulatory ECG

4.0

323.0

2579

6533

J96.1

ICD-10 Finland

Chronic respiratory failure

11.7

323.0

719

563

I42.0

ICD-10 Finland

Dilated cardiomyopathy

46.6

323.0

2307

509

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

323.0

5311

11351

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.8

323.0

1280

1541

C01BD01

ATC

amiodarone; systemic

13.0

323.0

1472

1088

WX872

NOMESCO Finland

Intensive care

5.1

323.0

1737

3285

I35.0

ICD-10 Finland

Aortic (valve) stenosis

4.3

323.0

1353

2942

WX892

NOMESCO Finland

Monitored bed care

4.3

323.0

2144

4919

205

Kela drug reimbursment

Chronic hypertension

2.5

323.0

5620

25781

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

323.0

4376

17228

I50.0

ICD-10 Finland

Congestive heart failure

423.3

323.0

4989

155

I47.2

ICD-10 Finland

Ventricular tachycardia

11.9

323.0

873

676

AN1

Coronary angiography

5.1

323.0

3876

8427

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

6.0

323.0

1722

2756

I50

ICD-10 Finland

Heart failure

38.2

323.0

1405

354

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.2

323.0

1471

3283

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

323.0

3295

12644

M10.9

ICD-10 Finland

Gout, unspecified

3.8

323.0

1733

4336

I50.9

ICD-10 Finland

Heart failure, unspecified

609.4

323.0

11242

661

K78

ICPC

Atrial fibrillation/flutter

4.9

323.0

2259

4589

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.8

323.0

5981

13501

C10AA05

ATC

atorvastatin; oral

2.0

323.0

7272

42468

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.2

323.0

1791

2426

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.6

323.0

2344

4215

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

323.0

10712

65698

B01AB05

ATC

enoxaparin; parenteral

2.1

323.0

5576

29277

C01DA14

ATC

isosorbide mononitrate; oral

3.7

323.0

3184

9000

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

7.7

323.0

902

1085

R06.0

ICD-10 Finland

Dyspnoea

4.2

323.0

6302

19281

C01AA05

ATC

digoxin; systemic

15.1

323.0

3004

2139

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.4

323.0

1288

1883

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

20.8

323.0

875

389

N18.8

ICD-10 Finland

Other chronic renal failure

7.2

323.0

870

1112

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

323.0

2725

9653

C07AB07

ATC

bisoprolol; oral

7.7

323.0

12017

46284

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.5

323.0

3337

13452

B01AC04

ATC

clopidogrel; oral

2.8

323.0

3517

12883

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.6

323.0

2204

4708

I48.2

ICD-10 Finland

Chronic atrial fibrillation

10.5

323.0

1028

911

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.6

323.0

5048

10977

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.5

323.0

820

880

C07AB02

ATC

metoprolol; systemic

2.3

323.0

3721

16258

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.5

323.0

1316

2734

201

Kela drug reimbursment

Chronic cardiac insufficiency

65.5

323.0

3206

542

C09DX04

ATC

valsartan and sacubitril; oral

377.1

323.0

743

K77

ICPC

Heart failure

30.2

323.0

806

246

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.0

323.0

5299

20481

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.0

323.0

2083

5083

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.5

323.0

5850

16221

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

6.2

323.0

1176

1768

A28

ICPC

Limited function/disability NOS

2.9

323.0

2795

9455

I25.2

ICD-10 Finland

Old myocardial infarction

6.1

323.0

1960

3134

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.4

323.0

2219

5021

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.1

323.0

5339

15768

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

6.2

323.0

1438

2195

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.4

323.0

1477

1679

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.1

323.0

10080

44195

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.7

323.0

1723

2492

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

25.9

323.0

1065

385

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

323.0

2673

7740

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.6

323.0

5429

23749

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.3

323.0

1854

4202

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.5

323.0

2259

5016

TK800

NOMESCO Finland

Hemodialysis

9.2

323.0

901

903

C03DA01

ATC

spironolactone; oral

14.3

323.0

5453

5051

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

323.0

2854

10353

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.3

323.0

1100

1629

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.6

323.0

1813

4812

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.2

323.0

4325

9443

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.1

323.0

1728

3996

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

19.2

323.0

587

277

A10AE04

ATC

insulin glargine; parenteral

3.9

323.0

2431

6216

T90

ICPC

Diabetes non-insulin dependent

2.3

323.0

4887

22509

R02

ICPC

Shortness of breath/dyspnoea

3.5

323.0

2753

7990

B01AA03

ATC

warfarin; systemic

6.8

323.0

6361

12873

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

45.8

316.7

409

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.9

312.7

717

736

E66.01

ICD-10 Finland

Obesity due to excess calories

3.7

310.4

1533

3923

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.6

305.4

1547

4039

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

9.4

304.5

677

658

ZX120

NOMESCO Finland

Intravenous

3.0

304.3

2031

6507

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

7.5

295.5

754

919

C10AA01

ATC

simvastatin; oral

1.9

293.2

7837

48096

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.4

290.1

1593

4426

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.2

289.8

1213

2672

R60.0

ICD-10 Finland

Localized oedema

2.8

289.1

2195

7620

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.6

288.8

1453

3765

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.1

287.7

1251

2855

N19

ICD-10 Finland

Unspecified kidney failure

6.1

286.8

851

1280

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.5

286.2

1131

2355

Angiography of the heart and coronary arteries

3.8

284.9

1369

3412

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.1

284.3

989

1800

GD1LA

NOMESCO Finland

11.0

283.9

578

475

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

282.6

5025

26390

A11CC03

ATC

alfacalcidol; systemic

7.2

282.3

739

935

J01MA12

ATC

levofloxacin; systemic

2.2

279.7

3414

15257

SPAT1262

SPAT

Handing over of treatment supplies

2.2

275.8

3593

16527

A10BH05

ATC

linagliptin; oral

4.1

274.9

1174

2631

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.2

273.8

1160

2580

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.1

273.2

813

1226

R4110

NOMESCO Finland

Physiotherapy

2.0

269.4

4669

24168

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

22.5

267.6

410

163

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

266.5

2099

7421

A12BA01

ATC

potassium chloride; oral

5.1

264.5

920

1671

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

11.2

264.3

533

429

J01FF01

ATC

clindamycin; systemic

2.0

264.3

4581

23670

WX722

NOMESCO Finland

PEEP

3.8

262.0

1247

3074

C09AA02

ATC

enalapril; systemic

2.1

262.0

3625

17060

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

38.5

261.1

349

A10AE05

ATC

insulin detemir; parenteral

3.8

260.7

1238

3045

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.2

260.6

887

1572

E66.00

ICD-10 Finland

Metabolic syndrome

3.6

258.4

1313

3416

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

255.7

1476

4238

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

254.6

4899

26258

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

65.4

252.9

308

SPAT1254

SPAT

Administration of medicine

2.4

251.0

2444

9702

1CX08

NOMESCO Finland

76.1

250.7

299

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

249.5

2164

8067

R03AC02

ATC

salbutamol; inhalant

1.8

249.4

7592

47588

L28

ICPC

Limited function/disability (L)

2.3

247.6

2661

11102

A10BB12

ATC

glimepiride; oral

3.2

242.9

1466

4339

A02BC02

ATC

pantoprazole; systemic

1.8

242.3

10007

68963

I44.2

ICD-10 Finland

Atrioventricular block, complete

6.7

240.4

664

904

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

239.6

2911

12850

Z49.1

ICD-10 Finland

Extracorporeal dialysis

9.4

238.6

528

507

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

238.2

2147

8159

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

10.2

237.7

502

442

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

13.4

236.9

439

294

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

235.3

2874

12704

A41.9

ICD-10 Finland

Sepsis, unspecified

4.8

234.1

853

1625

N02AA05

ATC

oxycodone; systemic

2.3

230.6

2577

10914

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

12.7

228.9

434

306

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

8.1

226.9

550

616

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

8.9

226.5

516

521

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.3

224.8

1291

3677

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

118.7

223.8

254

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.5

222.2

1170

3118

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.6

221.6

560

669

A10BH01

ATC

sitagliptin; oral

2.5

220.6

2000

7598

R50.9

ICD-10 Finland

Fever, unspecified

2.3

219.7

2324

9559

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.0

213.3

749

1369

B03XA02

ATC

darbepoetin alfa; parenteral

7.0

212.7

567

733

E66.8

ICD-10 Finland

Other obesity

3.9

212.0

965

2276

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.1

211.7

918

2072

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

9.0

210.9

478

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.3

210.6

694

1180

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

9.7

210.1

456

422

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

7.0

209.0

554

710

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.0

206.4

1361

4260

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

5.3

206.4

686

1178

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

206.1

4883

27640

N02BE01

ATC

paracetamol; systemic, rectal

2.0

205.8

12869

98641

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.1

203.6

2955

13964

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.3

201.1

815

1725

G47.3

ICD-10 Finland

Sleep apnoea

1.9

199.6

3833

20141

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

198.7

1211

3585

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

198.3

2434

10688

C02AC05

ATC

moxonidine; oral

3.3

194.1

1066

2925

E66.9

ICD-10 Finland

Obesity, unspecified

4.7

192.0

709

1365

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.4

191.6

757

1561

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

3.1

191.2

1164

3440

NHQ40

NOMESCO Finland

Amputation of toe

7.4

190.6

489

597

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.2

189.8

1117

3223

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

189.1

726

1455

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

188.2

2187

9346

127

Kela drug reimbursment

Transplant complication

6.7

187.8

514

689

A12AA04

ATC

calcium carbonate; oral

7.3

187.7

482

589

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.7

186.4

888

2172

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.9

184.8

1258

4008

R53

ICD-10 Finland

Malaise and fatigue

2.0

184.7

2818

13520

J96.0

ICD-10 Finland

Acute respiratory failure

10.3

184.4

387

336

I49.5

ICD-10 Finland

Sick sinus syndrome

4.2

184.1

770

1677

E87.5

ICD-10 Finland

Hyperkalaemia

8.0

183.8

447

502

J01DB01

ATC

cefalexin; oral

1.8

183.6

11973

90239

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.8

183.5

325

195

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

183.2

4427

24996

I20.09

ICD-10 Finland

Unstable angina

3.1

182.7

1136

3406

N02AX02

ATC

tramadol; systemic, rectal

1.7

181.7

6613

42140

AP1

Catheterization of the left side of the heart

6.6

179.1

498

682

SPAT1263

SPAT

Sampling

1.7

178.1

6288

39651

L04AA06

ATC

mycophenolic acid; systemic

5.9

177.2

532

806

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

177.2

1613

6092

C07AG02

ATC

carvedilol; oral

2.8

177.0

1243

4036

C08DB01

ATC

diltiazem; oral

3.4

175.3

939

2522

XF640

NOMESCO Finland

4.2

175.2

718

1532

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.2

173.5

1012

2896

V03AE01

ATC

polystyrene sulfonate; oral

9.1

172.4

387

380

A06AD11

ATC

lactulose; oral

2.2

171.8

2096

9121

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

171.4

1201

3889

SPAT1229

SPAT

Assessment of need for aid

2.6

171.1

1398

4968

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.7

170.3

392

402

K84

ICPC

Heart disease other

4.4

170.3

673

1386

K07

ICPC

Swollen ankles/oedema

3.5

170.3

887

2330

J01MA14

ATC

moxifloxacin; systemic

2.4

170.2

1572

5976

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.2

169.6

570

989

A10BK01

ATC

dapagliflozin; oral

3.1

166.8

1002

2926

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

31.3

166.7

233

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

25.4

166.6

246

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

166.1

4405

25425

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

166.0

2649

12868

C07AA07

ATC

sotalol; systemic

3.9

164.9

751

1764

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

164.0

860

2269

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

164.0

2809

14006

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

163.6

1060

3258

N18.0

ICD-10 Finland

End-stage renal disease

8.9

162.6

370

372

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

162.3

1173

3870

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

161.7

1573

6131

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.3

161.6

339

294

A08

ICPC

Swelling

3.5

160.6

840

2211

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

160.6

2459

11738

R04.0

ICD-10 Finland

Epistaxis

2.6

160.3

1311

4654

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

160.1

1790

7467

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

3.1

160.1

982

2908

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

159.8

837

2206

XG466

NOMESCO Finland

Sleep oxymetry

3.6

158.0

771

1919

I34.1

ICD-10 Finland

Mitral (valve) prolapse

4.2

157.8

645

1371

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

157.7

4914

29616

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

157.6

4361

25402

K99

ICPC

Cardiovascular disease other

4.3

154.8

625

1313

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.2

154.5

643

1390

250

Kela drug reimbursment

245.2

154.1

166

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

5.3

153.9

506

855

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.5

153.7

595

1199

XF402

NOMESCO Finland

ECG with work load test

2.1

153.4

2144

9850

A10BB01

ATC

glibenclamide; oral

4.1

151.5

635

1382

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

151.2

1932

8541

TFP34

NOMESCO Finland

Electrophysiological investigation

3.7

150.2

726

1791

Z94.1

ICD-10 Finland

Heart transplant status

48.2

149.6

191

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

149.4

1432

5527

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

22.8

149.3

227

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

148.9

679

1594

AA1

Conventional CABG

5.4

148.6

479

791

A10BK03

ATC

empagliflozin; oral

2.4

148.3

1458

5701

I42.8

ICD-10 Finland

Other cardiomyopathies

16.5

146.3

248

133

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

145.4

1032

3358

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

145.4

1036

3380

WX882

NOMESCO Finland

High dependency care

4.0

144.2

634

1441

B01AF01

ATC

rivaroxaban; oral

2.0

142.7

2196

10453

C08CA02

ATC

felodipine; oral

2.2

142.5

1640

6907

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

142.5

4210

24830

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

142.4

919

2812

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

141.3

2124

10015

C03AA03

ATC

hydrochlorothiazide; oral

2.2

139.6

1680

7216

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.9

139.1

614

1400

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

138.9

928

2901

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

138.7

1826

8152

SPAT1255

SPAT

Intravenous administration of medicine

2.5

137.0

1197

4389

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

10.0

136.4

290

258

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

136.0

1744

7696

WX730

NOMESCO Finland

Conventional respirator

5.9

135.8

410

625

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.8

135.7

486

903

3AC01

NOMESCO Finland

8.4

135.1

316

333

M10

ICD-10 Finland

Gout

2.9

135.1

919

2906

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

134.3

873

2681

N05CF01

ATC

zopiclone; oral

1.6

134.2

4578

27970

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

4.5

134.0

515

1029

TK810

NOMESCO Finland

Hemofiltration

10.9

133.8

272

222

N17.8

ICD-10 Finland

Other acute renal failure

7.7

133.7

332

385

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

133.4

1852

8443

C07AB03

ATC

atenolol; systemic

2.6

132.5

1040

3587

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

9.9

132.1

282

253

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.9

131.2

459

831

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.1

130.9

443

773

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

12.0

128.5

249

184

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4.4

128.4

498

1004

M10.0

ICD-10 Finland

Idiopathic gout

3.4

128.4

693

1864

A10AA02

ATC

4.0

128.1

555

1243

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

128.1

1352

5452

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.0

127.9

562

1275

A04

ICPC

Weakness/tiredness general

2.1

126.3

1671

7455

AN4

Balloon angioplasty and drug eluding stent

3.1

125.9

747

2153

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.4

125.0

317

380

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.3

124.5

294

315

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.7

124.4

339

451

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.0

123.8

792

2402

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.5

122.7

465

916

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

122.3

1688

7655

C09CA01

ATC

losartan; oral

1.6

121.9

3868

23052

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.2

121.5

314

387

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.8

121.5

440

827

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

121.2

928

3152

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

121.1

850

2738

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

121.0

1264

5068

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

120.2

816

2573

Z94.0

ICD-10 Finland

Kidney transplant status

6.4

120.1

338

470

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.1

119.8

722

2102

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

119.6

10645

103880

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.5

119.2

610

1573

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

118.5

371

591

C09CA03

ATC

valsartan; oral

2.1

118.3

1580

7066

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.7

118.1

366

576

A10BJ02

ATC

liraglutide; parenteral

3.8

118.0

545

1291

C08CA13

ATC

lercanidipine; oral

1.9

117.8

2181

11033

B01AE07

ATC

dabigatran etexilate; oral

2.8

117.3

821

2639

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

5.6

116.9

365

580

S18

ICPC

Laceration/cut

1.5

116.6

6502

44237

R55

ICD-10 Finland

Syncope and collapse

2.0

116.0

1631

7442

JN4AD

NOMESCO Finland

Body CT examination

2.1

116.0

1443

6258

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

115.1

5346

34876

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.5

115.1

590

1523

J94.8

ICD-10 Finland

Other specified pleural conditions

5.5

115.1

367

598

160

Kela drug reimbursment

exenatide

3.9

114.8

513

1181

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

114.4

807

2605

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

114.3

1035

3857

J81

ICD-10 Finland

Pulmonary oedema

29.2

114.2

162

WW500

NOMESCO Finland

Blood transfusion

2.9

113.4

751

2328

H3601, E113

ICD-10 Finland

5.2

113.2

377

646

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

113.1

2084

10510

SPAT1301

SPAT

No procedures

1.6

112.5

4561

28786

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

6.8

112.1

300

389

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

111.5

1025

3848

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.8

111.5

336

511

C10AX09

ATC

ezetimibe; oral

1.9

111.4

2046

10302

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

263.5

111.0

119

SPAT1216

SPAT

Assessment of functional ability

1.8

111.0

2248

11696

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

8.8

110.9

253

256

E86

ICD-10 Finland

Volume depletion

4.5

110.6

421

833

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.2

110.4

286

354

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.3

110.2

363

614

137

Kela drug reimbursment

Uraemia requiring dialysis

7.8

110.2

270

307

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.4

110.1

218

169

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

13.1

109.7

204

138

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

109.4

517

1248

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.4

109.4

1070

4145

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.2

108.7

258

279

AS7

Arrhythmia pacemaker insertion VVI (R) S

39.4

108.0

143

TFJ02

NOMESCO Finland

Muscle biopsy of heart

32.4

106.4

147

I20.01

ICD-10 Finland

Unstable angina

3.3

106.3

591

1623

J46

ICD-10 Finland

Status asthmaticus

3.9

106.2

468

1064

I20.00

ICD-10 Finland

Unstable angina

3.4

106.0

561

1484

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

105.7

791

2647

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

104.5

993

3788

J01CF05

ATC

flucloxacillin; systemic

3.0

103.3

662

2007

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

103.2

1087

4359

UJF32

NOMESCO Finland

Coloscopy

1.6

102.7

3927

24326

SPAT1097

SPAT

Recording of ECG

1.7

102.7

2428

13224

E87.6

ICD-10 Finland

Hypokalaemia

3.3

102.6

573

1578

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

102.4

5608

37644

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

102.2

1232

5258

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

101.3

1852

9286

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

101.2

3427

20584

AP2

Catheterization of the right side of the heart

17.2

101.0

168

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

100.9

2974

17229

WX740

NOMESCO Finland

Nitrogen oxide therapy

32.2

100.5

139

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

100.5

645

1957

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.8

100.5

458

1072

Coronary artery bypass surgery

5.0

100.5

349

627

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.3

100.3

541

1451

H3603, E103

ICD-10 Finland

7.2

100.3

258

316

S76

ICPC

Skin infection other

2.5

99.9

855

3084

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.8

99.4

358

669

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.1

98.9

198

157

ZZA00

NOMESCO Finland

Split skin graft

3.3

98.8

552

1520

H3600, E113

ICD-10 Finland

5.4

98.8

320

531

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

98.7

559

1555

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

98.5

1057

4274

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.5

97.3

818

2921

C02EA02

ATC

2.7

97.2

711

2344

L17

ICPC

Foot/toe symptom/complaint

1.6

97.1

3649

22445

B01AB10

ATC

tinzaparin; parenteral

2.1

97.1

1170

4986

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

97.0

1140

4805

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

7.1

96.9

252

314

J96.9

ICD-10 Finland

Respiratory failure, unspecified

12.3

96.9

185

133

V03AE02

ATC

sevelamer; oral

10.0

96.5

204

180

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

18.9

95.6

154

H02AB07

ATC

prednisone; oral

1.8

95.6

2016

10578

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.0

95.5

411

914

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.9

95.4

616

1876

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

94.1

6708

47212

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

94.0

6413

44744

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

93.2

1480

7043

FL1AC

NOMESCO Finland

Left cardioangiography

4.5

93.2

356

707

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.6

93.2

256

345

A41.8

ICD-10 Finland

Other specified sepsis

4.6

93.0

346

669

K92.1

ICD-10 Finland

Melaena

2.5

92.7

813

2968

C09BA02

ATC

enalapril and diuretics; systemic

2.0

92.6

1414

6630

H3603, E113

ICD-10 Finland

6.6

92.5

254

342

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

69.8

92.4

111

PE1AT

NOMESCO Finland

Femoral artery PTA

5.5

92.4

290

464

R04.2

ICD-10 Finland

Haemoptysis

2.9

92.3

602

1844

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.8

92.2

329

609

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

7.3

92.0

234

282

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.4

92.0

355

712

J01MA02

ATC

ciprofloxacin; systemic

1.5

91.3

5455

37001

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

91.3

1887

9825

N05CD07

ATC

temazepam; oral

1.8

91.2

1759

8953

AS4

Physiological pacemaker insertion DDD (R)

5.4

90.5

291

479

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

6.8

90.5

242

314

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.4

90.4

466

1207

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.8

90.2

411

962

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.8

90.2

273

418

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

90.1

929

3684

K83

ICPC

Heart valve disease NOS

5.7

89.8

277

434

WX002

NOMESCO Finland

Sedation and analgesia

1.6

89.5

3018

18022

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

89.0

5686

39024

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

5.1

89.0

299

518

AN3

Balloon angioplasty and metallic stent

3.1

89.0

525

1503

R95

ICPC

Chron obstructive pulmonary disease

3.1

88.6

520

1483

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.6

88.5

426

1044

J01DA01

ATC

[U] cefalexin; systemic

1.4

88.0

8318

61393

I42

ICD-10 Finland

Cardiomyopathy

43.6

88.0

114

K28

ICPC

Limited function/disability (K)

3.8

88.0

402

943

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.6

87.9

431

1073

M01AH05

ATC

etoricoxib; oral

0.7

87.8

5803

61766

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

87.7

698

2415

C08DA01

ATC

verapamil; systemic

2.7

86.8

656

2203

Z49.2

ICD-10 Finland

Other dialysis

7.3

86.8

221

267

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

86.8

1459

7077

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.5

86.8

440

1125

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.1

86.7

251

363

T89

ICPC

Diabetes insulin dependent

2.9

86.7

577

1792

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.8

86.7

211

238

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

85.6

723

2584

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

10.7

85.5

174

143

A10AA01

ATC

3.6

85.5

420

1047

FXG00

NOMESCO Finland

Insertion and use of IABP

30.8

85.2

119

SPAT1252

SPAT

Overall medication plan or its review

2.1

85.2

1067

4616

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.6

84.9

679

2356

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.6

84.4

410

1013

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

8.4

84.3

197

208

R11

ICD-10 Finland

Nausea and vomiting

2.1

84.0

1034

4436

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

13.8

84.0

152

R18

ICD-10 Finland

Ascites

3.8

83.9

380

885

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

27.8

83.8

120

N03AX16

ATC

pregabalin; oral

1.5

83.8

3301

20408

AP4

Myocardial biopsy

40.3

83.6

110

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.2

83.5

275

466

XF409

NOMESCO Finland

Other special ECG

8.9

83.2

187

185

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.6

83.2

306

585

SPAT1104

SPAT

Monitoring of emergency patient

2.1

82.8

1058

4613

R03DA04

ATC

theophylline; systemic, rectal

2.6

82.4

652

2246

K29

ICPC

Cardiovascular sympt/complt other

2.5

82.3

718

2612

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

62.9

82.1

100

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

11.6

81.6

160

122

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

81.3

832

3283

Catheterization and pressure measurement of the left side of the heart

4.4

81.3

312

623

AP3

Catheterization of the right and left side of the heart

20.3

81.0

127

SPAT1211

SPAT

Application of soft bandage

1.9

80.9

1346

6496

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

80.5

692

2499

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.7

80.4

377

904

J01CA04

ATC

amoxicillin; systemic

1.4

80.4

10814

84399

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.0

80.4

273

479

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

80.3

1990

10909

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.3

80.2

317

651

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.7

79.3

285

532

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.3

79.1

311

636

A10BJ06

ATC

semaglutide; parenteral

2.7

78.9

582

1925

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.0

78.9

494

1473

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

78.9

607

2059

SPAT1234

SPAT

Support of social functional capacity

2.5

78.7

665

2378

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

78.5

339

757

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.1

78.1

173

167

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.6

78.0

380

941

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

6.4

77.8

217

299

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

53.2

77.7

B05DA

ATC

Isotonic solutions

6.9

77.6

205

262

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.4

77.2

246

401

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

243.9

77.2

C09AA04

ATC

perindopril; oral

2.2

77.0

849

3465

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.4

76.5

167

157

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

4.5

76.5

288

564

NFQ20

NOMESCO Finland

Amputation of femur

11.0

76.4

153

122

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

76.3

2961

18179

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

3.9

76.1

332

748

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

76.0

464

1359

3A064

NOMESCO Finland

11.9

76.0

147

109

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.6

75.5

278

532

JN4BD

NOMESCO Finland

Extensive body CT

1.7

75.4

1801

9752

NGQ20

NOMESCO Finland

Amputation of lower leg

10.3

75.3

156

133

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

75.1

560

1865

SPAT1251

SPAT

Organisation of medication

2.8

75.0

515

1629

V03AE03

ATC

lanthanum carbonate; oral

12.1

74.6

143

104

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.8

74.0

500

1566

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.7

73.8

341

808

N05BA04

ATC

oxazepam; oral

1.5

73.7

3041

18906

H36.01

ICD-10 Finland

Diabetic maculopathy

4.9

73.7

256

461

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

6.5

73.5

203

276

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

23.6

73.5

110

N05AH04

ATC

quetiapine; oral

1.7

73.1

1793

9778

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

73.1

1002

4489

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.2

73.0

208

295

AN2

Balloon angioplasty, including several vessels

2.7

72.9

528

1727

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

20.0

72.5

114

N30.0

ICD-10 Finland

Acute cystitis

1.7

72.5

1619

8588

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.3

72.3

387

1032

B05DB

ATC

Hypertonic solutions

7.6

72.3

179

208

C08CA05

ATC

nifedipine; systemic

2.1

72.2

873

3710

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

72.2

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

7.6

72.0

179

209

J01FA06

ATC

roxithromycin; oral

1.4

71.9

5237

36381

B01AB04

ATC

dalteparin; parenteral

2.3

71.6

751

2995

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

68.7

71.6

280

Kela drug reimbursment

Clopidogrel

4.4

71.3

279

568

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.4

71.3

199

275

E0000UV

ATC

1.4

71.2

4954

34122

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.4

71.0

273

546

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

7.6

70.8

175

203

K08.3

ICD-10 Finland

Retained dental root

1.9

70.6

1067

4959

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.9

70.6

310

703

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.9

70.5

246

445

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

70.5

1179

5689

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

70.3

436

1291

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.6

70.1

554

1908

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

7.3

69.9

177

213

I95.9

ICD-10 Finland

Hypotension, unspecified

4.5

69.8

265

524

WW200

NOMESCO Finland

Immunization

2.8

69.7

471

1475

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.8

69.4

315

735

A10BX07

ATC

[U] liraglutide; parenteral

3.9

69.2

308

707

Z71.8

ICD-10 Finland

Other specified counselling

1.5

69.0

2893

18012

SPAT1260

SPAT

Consultation of another employee

1.5

69.0

2505

15098

ZXA00

NOMESCO Finland

Right side

1.4

68.9

3843

25360

L04AD01

ATC

ciclosporin; systemic

3.4

68.9

354

915

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

68.9

615

2264

B01AC24

ATC

ticagrelor; oral

2.4

68.5

637

2391

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

68.3

692

2712

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.0

68.2

200

295

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

20.7

68.2

106

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

68.1

551

1922

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

68.1

326

796

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.2

68.0

276

582

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.1

68.0

227

391

E66.0

ICD-10 Finland

Obesity due to excess calories

4.8

68.0

243

451

WX213

NOMESCO Finland

Lower leg blockade

6.2

68.0

194

276

7AX01

NOMESCO Finland

133.3

68.0

R33

ICD-10 Finland

Retention of urine

1.9

67.8

1039

4855

212

Kela drug reimbursment

Gout

3.4

67.4

348

903

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.6

67.1

183

245

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

8.2

67.0

158

170

AB2

AVR bio, stent

9.1

66.6

148

144

ZX108

NOMESCO Finland

Inhalation

6.0

66.6

194

284

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

66.1

468

1510

N05BA01

ATC

diazepam; systemic, rectal

1.6

65.9

1780

9947

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

65.9

473

1538

ZXA05

NOMESCO Finland

Left side

1.4

65.7

3553

23270

H02AB04

ATC

methylprednisolone; systemic

1.6

65.2

1924

11006

WZC30

NOMESCO Finland

Teaching

1.6

65.1

2028

11762

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

65.0

497

1676

XF622

NOMESCO Finland

Measurement of minute volume of heart

11.1

64.8

129

102

TGC00

NOMESCO Finland

Bronchial lavation

2.7

64.5

464

1510

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.4

64.4

337

884

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.0

64.3

168

212

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.1

63.9

215

374

AC4

MVP

8.7

63.8

145

147

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

63.4

2280

13681

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

63.3

N06AX11

ATC

mirtazapine; oral

1.4

63.1

3951

26555

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

63.0

3113

19999

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

62.7

1561

8525

B01AF03

ATC

edoxaban; oral

3.6

62.6

300

734

C01BC04

ATC

flecainide; systemic

2.3

62.5

630

2462

162

Kela drug reimbursment

liraglutide

3.9

62.4

271

609

R06.2

ICD-10 Finland

Wheezing

2.3

62.3

608

2340

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

62.2

593

2254

Z51.5

ICD-10 Finland

Palliative care

2.0

62.2

871

3929

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

16.6

62.1

104

B03XA01

ATC

erythropoietin; parenteral

6.2

62.1

177

252

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.3

62.0

335

900

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.2

61.8

145

155

AS2

Ventricular pacemaker insertion VVI (R)

12.1

61.7

118

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.3

61.7

244

503

E66

ICD-10 Finland

Obesity

2.4

61.6

547

2006

T92

ICPC

Gout

3.1

61.6

371

1078

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

61.5

2397

14639

M79.6

ICD-10 Finland

Pain in limb

1.4

61.4

4652

32291

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

61.3

3476

22919

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.3

61.0

242

500

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.0

61.0

262

583

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

60.7

900

4148

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

4.5

60.6

227

443

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

11.8

60.6

117

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

60.5

1260

6523

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

60.3

1647

9219

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

60.3

3516

38962

SPAT1151

SPAT

Treatment of major wounds

4.0

60.2

258

573

Single vessel balloon catheter extension

3.1

60.0

347

979

C02CA01

ATC

prazosin; oral

4.1

59.9

248

534

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.1

59.7

353

1012

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

59.6

949

4490

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.6

59.5

221

428

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

6.0

59.4

174

257

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

6.6

59.2

160

212

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.7

59.1

424

1378

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

5.2

58.9

194

330

C09AA01

ATC

captopril; oral

3.7

58.9

276

663

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.3

58.8

232

477

A10AE06

ATC

insulin degludec; parenteral

2.7

58.6

427

1402

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

4.3

58.6

233

483

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

58.6

2297

14031

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.2

58.2

192

327

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.7

58.0

177

275

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

57.9

345

995

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

56.8

510

1881

U14

ICPC

Kidney symptom/complaint

3.8

56.8

253

582

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

7.4

56.6

142

169

R4190

NOMESCO Finland

Nutritional therapy

2.4

56.6

503

1847

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.6

56.4

174

274

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.3

56.4

224

464

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

82.7

56.4

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.2

56.2

611

2474

RS221

NOMESCO Finland

3.8

56.1

255

597

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

56.1

334

963

SPAT1310

SPAT

Counselling related to known health issue

1.4

56.0

4358

30269

A08AB01

ATC

orlistat; oral

4.7

56.0

200

372

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.7

56.0

262

629

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.3

55.8

115

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.9

55.6

363

1113

EBA00

NOMESCO Finland

Extraction of tooth

1.4

55.4

4203

29054

A10BH02

ATC

vildagliptin; oral

3.0

55.3

341

1007

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.7

55.0

167

258

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

55.0

4444

31036

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.9

55.0

145

186

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.9

54.9

163

245

W19

ICD-10 Finland

Unspecified fall

1.7

54.9

1179

6155

TFP35

NOMESCO Finland

Electroanatomical mapping

3.2

54.4

300

819

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

54.3

917

4426

H05BX01

ATC

cinacalcet; oral

6.5

54.3

149

202

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

7.6

54.3

133

153

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

18.6

54.2

Catheterization and pressure measurement of the right side of the heart

10.6

54.2

110

T82

ICPC

Obesity

2.5

54.0

462

1662

A07AA09

ATC

vancomycin; oral

4.1

53.9

222

476

K90

ICPC

Stroke/cerebrovascular accident

2.6

53.8

411

1386

AQ1

Conventional electrophysiological examination

3.7

53.8

248

588

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

14.0

53.8

742

NOMESCO Finland

11.4

53.5

105

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.9

53.5

107

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

53.4

260

645

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

8.3

53.4

124

131

OAB43

SPAT

0.5

53.2

324

6103

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.0

53.2

226

499

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

5.6

53.0

162

253

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

11.1

52.9

105

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.6

52.5

255

632

CKC12

NOMESCO Finland

Photocoagulation of retina

2.1

52.3

666

2887

C10AA03

ATC

pravastatin; oral

1.7

52.2

1076

5542

R03BA02

ATC

budesonide; inhalant

1.5

52.2

2072

12659

TK820

NOMESCO Finland

Peritoneal dialysis

7.6

52.1

128

148

E000001

ATC

1.5

51.7

2358

14823

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

14.5

51.7

WX900

NOMESCO Finland

Resuscitation

9.4

51.7

112

105

N05AA02

ATC

levomepromazine; systemic

2.2

51.5

567

2309

L04AX01

ATC

azathioprine; systemic

2.1

51.4

594

2472

SPAT1325

SPAT

Vaccination

1.3

51.2

4778

34030

A29

ICPC

General symptom/complaint other

1.6

50.9

1394

7789

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.0

50.7

307

894

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

462.8

50.7

N05AX08

ATC

risperidone; systemic

1.9

50.7

776

3616

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

3.3

50.7

271

724

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

13.8

50.6

5CM18

NOMESCO Finland

8.4

50.5

117

123

K65.0

ICD-10 Finland

Acute peritonitis

4.1

50.5

206

438

UJF92

NOMESCO Finland

Capsular endoscopy

3.0

50.5

314

933

B82

ICPC

Anaemia other/unspecified

2.8

50.5

355

1142

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

11.3

50.3

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

31.9

50.2

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.5

50.1

188

369

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

50.1

1014

5194

WX110

NOMESCO Finland

Local anesthesy

1.3

50.1

9100

71099

C09CA06

ATC

candesartan; oral

1.4

50.0

2848

18673

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.3

49.8

266

710

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

49.7

869

4242

I27.0

ICD-10 Finland

Primary pulmonary hypertension

16.5

49.7

R42

ICD-10 Finland

Dizziness and giddiness

1.4

49.4

2713

17666

J20

ICD-10 Finland

Acute bronchitis

1.7

49.2

1206

6534

I95.1

ICD-10 Finland

Orthostatic hypotension

2.5

49.2

409

1448

C10AA04

ATC

fluvastatin; oral

1.6

49.1

1247

6822

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

48.9

933

4687

R31

ICD-10 Finland

Unspecified haematuria

1.6

48.9

1347

7534

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

48.7

923

4629

WX890

NOMESCO Finland

Intesive care monitoring

5.6

48.5

148

231

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.5

48.4

111

115

SPAT1172

SPAT

Guidance concerning hydration

3.1

48.4

283

807

R03BB01

ATC

ipratropium bromide; inhalant

2.4

48.3

425

1552

RD210

NOMESCO Finland

3.2

48.3

266

727

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

5.2

48.1

157

265

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

48.1

896

4469

AB1

AVR mechanical

7.3

47.9

121

146

342

Kela drug reimbursment

Dronedarone

4.2

47.9

191

398

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

47.9

1201

6545

N06AB04

ATC

citalopram; systemic

1.4

47.9

2556

16546

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.5

47.9

385

1339

5253

FHL

Cardiac lung machine

7.6

47.7

117

135

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.0

47.7

106

104

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

8.8

47.7

107

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

35.0

47.6

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.9

47.6

125

160

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

47.6

316

981

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

47.5

3960

27647

TK830

NOMESCO Finland

Ultrafiltration

47.8

47.4

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

47.4

445

1679

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

47.3

1022

5335

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

47.2

145

228

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

47.0

642

2863

H26.4

ICD-10 Finland

After-cataract

1.7

46.8

1115

5987

R03AC13

ATC

formoterol; inhalant

2.0

46.8

629

2787

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

46.6

1172

6391

M10.3

ICD-10 Finland

Gout due to impairment of renal function

8.1

46.5

110

120

I97.0

ICD-10 Finland

Postcardiotomy syndrome

7.4

46.4

116

138

L04AA01

ATC

[U] ciclosporin; systemic

3.1

46.3

270

767

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

46.2

696

3220

R03AC12

ATC

salmeterol; inhalant

2.1

46.2

545

2288

R03BA05

ATC

fluticasone; inhalant

1.5

46.1

2080

13018

I11

ICD-10 Finland

Hypertensive heart disease

6.4

45.9

127

175

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

45.9

2124

13362

WX402

NOMESCO Finland

General anaesthesia

1.4

45.8

2194

13892

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.8

45.8

309

968

R4120

NOMESCO Finland

Occupational therapy

1.8

45.7

836

4141

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

12.4

45.7

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

45.6

198

447

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.9

45.6

134

200

E05.89

ICD-10 Finland

Other thyrotoxicosis

9.2

45.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

45.4

282

836

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

45.2

613

2725

S20

ICPC

Corn/callosity

2.7

45.2

326

1065

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.0

45.2

282

841

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

45.1

477

1907

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

45.0

1274

7169

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.0

44.7

188

412

WX212

NOMESCO Finland

Femoral plexus blockade

3.0

44.7

273

802

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

44.6

1035

5516

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.9

44.6

283

853

3025

Kela drug reimbursment

Calcium carbonate

8.9

44.4

RS220

NOMESCO Finland

3.7

44.4

208

501

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

44.3

1424

8266

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.7

44.3

158

295

G04BE03

ATC

sildenafil; oral

2.8

44.2

293

909

SPAT1281

SPAT

Other administrative function

1.7

44.1

1038

5554

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

76.0

44.1

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

44.1

189

422

B80

ICPC

Iron deficiency anaemia

3.1

44.0

254

718

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

6.8

43.9

116

150

PD5AD

NOMESCO Finland

CT of aorta

3.1

43.9

262

757

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.9

43.8

129

193

D64.8

ICD-10 Finland

Other specified anaemias

3.2

43.8

241

659

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

43.8

820

4092

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

43.7

350

1216

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

36.3

43.5

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

43.3

341

1173

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

5.9

43.3

127

189

X57

ICD-10 Finland

Unspecified privation

2.6

43.1

324

1083

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.8

43.1

129

197

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

43.1

374

1357

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

43.1

3760

39866

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

43.0

379

1385

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

12.2

42.9

ZXA10

NOMESCO Finland

Bilateral

1.4

42.9

2372

15415

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

42.9

4264

30447

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

42.8

254

733

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

42.7

5870

43792

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

5.0

42.7

145

257

C07AB05

ATC

betaxolol; oral

2.4

42.7

398

1499

B01AC07

ATC

dipyridamole; systemic

2.3

42.5

407

1550

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.0

42.4

144

255

C02DE04

ATC

3.0

42.4

261

772

N18

ICD-10 Finland

Chronic kidney disease

4.7

42.3

151

282

J43.9

ICD-10 Finland

Emphysema, unspecified

3.3

42.3

229

619

R81

ICPC

Pneumonia

2.2

42.3

443

1765

R4180

NOMESCO Finland

Podiatric therapy

3.7

42.3

194

460

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

42.2

581

2600

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.4

42.1

161

323

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.3

42.1

227

612

A02BC01

ATC

omeprazole; systemic

1.3

41.9

3487

24239

J45.8

ICD-10 Finland

Mixed asthma

2.4

41.9

383

1425

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

46.4

41.8

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.1

41.7

240

678

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

41.6

1160

6496

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

41.6

483

2013

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.9

41.5

108

137

C01BD07

ATC

dronedarone; oral

4.3

41.5

161

328

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

6.0

41.4

119

173

SPAT1167

SPAT

Insertion of urinary catheter

2.2

41.2

423

1668

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

41.2

616

2840

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

7.4

41.2

103

123

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

41.1

379

1420

M86.6

ICD-10 Finland

Other chronic osteomyelitis

6.9

41.1

107

136

N03AX12

ATC

gabapentin; oral

1.4

41.0

1961

12395

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

40.8

601

2758

H3601, E103

ICD-10 Finland

4.3

40.8

160

329

J45

ICD-10 Finland

Asthma

1.6

40.8

1131

6324

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

40.7

281

895

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

40.7

473

1974

R07.3

ICD-10 Finland

Other chest pain

1.6

40.6

1215

6923

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

19.3

40.6

L84

ICD-10 Finland

Corns and callosities

2.1

40.5

466

1934

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

30.7

40.5

I20.91

ICD-10 Finland

Angina pectoris, unspecified

3.5

40.5

202

513

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.2

40.5

162

340

A10BX04

ATC

[U] exenatide; parenteral

3.3

40.4

217

583

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

5.2

40.3

131

221

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

40.0

294

970

H25.8

ICD-10 Finland

Other senile cataract

1.5

40.0

1337

7822

R60.1

ICD-10 Finland

Generalized oedema

5.8

40.0

119

181

I48.3

ICD-10 Finland

Typical atrial flutter

4.4

39.8

153

309

R28

ICPC

Limited function/disability (R)

3.4

39.8

203

525

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.1

39.5

162

348

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

8.0

39.4

102

288

Kela drug reimbursment

Febuxostat

6.4

39.3

108

148

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.1

39.2

482

2058

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.3

39.2

2313

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

39.2

286

942

I95.2

ICD-10 Finland

Hypotension due to drugs

5.2

39.2

127

214

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.9

39.0

578

2660

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

39.0

576

2648

ZPB22

NOMESCO Finland

Autograft of vein

5.6

38.9

118

184

K92

ICPC

Atherosclerosis/periph vascular dis

3.2

38.9

215

591

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.4

38.8

200

521

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

38.7

1433

8577

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.0

38.6

130

229

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

38.6

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.9

38.5

245

742

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

38.5

347

1285

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.5

38.5

309

1074

A98

ICPC

Health maint/preventive medicine

0.7

38.4

13276

119961

A10BX01

ATC

guar gum; systemic

2.0

38.4

492

2139

A10BG03

ATC

pioglitazone; oral

2.2

38.4

405

1618

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

38.4

390

1532

N05AF03

ATC

chlorprothixene; systemic

2.4

38.3

355

1333

FXE00

NOMESCO Finland

Use of ECLA

42.9

38.1

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

17.5

38.1

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.4

37.9

193

499

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.4

37.9

193

499

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

37.8

885

4723

WX721

NOMESCO Finland

Oxygen concentrator therapy

11.0

37.8

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.8

37.7

133

246

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.9

37.6

129

232

H02AB09

ATC

hydrocortisone; systemic

2.5

37.5

311

1102

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.3

37.5

199

531

M04AA03

ATC

febuxostat; oral

6.6

37.4

100

132

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

37.4

710

3557

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.9

37.4

127

226

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.5

37.3

115

183

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.5

37.2

315

1129

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

24.9

37.1

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

37.0

436

1828

K87

ICPC

Hypertension complicated

2.4

37.0

334

1237

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

339.4

37.0

K80

ICPC

Cardiac arrhythmia NOS

1.6

37.0

998

5537

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

36.9

853

4535

A10BG02

ATC

rosiglitazone; oral

2.9

36.9

243

751

R2110

NOMESCO Finland

Giving the first information

1.8

36.9

728

3690

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.4

36.9

116

189

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

10.6

36.8

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

4.3

36.7

143

293

A01

ICPC

Pain general/multiple sites

1.7

36.7

907

4913

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.3

36.7

117

194

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.4

36.6

326

1201

N03AG01

ATC

valproic acid; systemic, rectal

1.8

36.5

667

3300

K92.0

ICD-10 Finland

Haematemesis

2.5

36.3

309

1111

H03BB01

ATC

carbimazole; oral

2.0

36.3

462

2002

E87.2

ICD-10 Finland

Acidosis

5.1

36.2

119

204

5AB14

NOMESCO Finland

11.1

36.1

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

8.8

35.9

C02DE02

ATC

3.7

35.8

164

389

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

35.8

855

4587

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

10.9

35.8

K60

ICPC

Cardiovascular, Result test/procedure

4.1

35.7

145

309

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

170.6

35.7

J01AA02

ATC

doxycycline; systemic

1.3

35.7

10594

85870

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

7.4

35.6

104

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

116.7

35.6

A03

ICPC

Fever

1.5

35.5

1504

9258

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

35.5

409

1700

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.0

35.4

147

320

R96

ICPC

Asthma

1.6

35.3

1060

6039

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.8

35.3

157

364

A10AB06

ATC

insulin glulisine; parenteral

3.4

35.2

180

467

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

35.2

1486

9142

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.5

35.1

175

445

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

3.7

35.1

162

387

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.7

34.7

124

233

R03AC03

ATC

terbutaline; inhalant

1.5

34.7

1537

9543

L14

ICPC

Leg/thigh symptom/complaint

1.6

34.6

919

5074

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

4.3

34.5

135

278

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

5.1

34.5

114

197

EBA30

NOMESCO Finland

Excision of root of tooth

1.7

34.5

718

3700

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.7

34.4

243

786

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

34.4

291

1043

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

34.4

1533

9530

D09AB01

ATC

zinc bandage without supplements; topical

2.6

34.4

270

927

G72.8

ICD-10 Finland

Other specified myopathies

3.0

34.3

210

620

AC2

MVR bio

31.7

34.3

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.6

34.3

125

240

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

34.2

594

2889

N05AH03

ATC

olanzapine; systemic

1.8

34.2

607

2974

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

34.2

361

1445

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

34.1

171

437

RS222

NOMESCO Finland

3.3

34.1

179

474

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.0

34.1

144

319

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

2.9

34.0

214

645

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

4.2

33.9

135

283

RJ411

NOMESCO Finland

4.9

33.8

116

209

A10BB07

ATC

glipizide; oral

3.8

33.6

149

345

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

33.5

570

2754

Electrophysiological Special Examination

4.2

33.5

132

274

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

5.3

33.5

107

178

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

4.9

33.4

115

208

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.4

33.4

126

251

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

33.3

365

1485

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.7

33.3

236

766

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

15.8

33.2

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

33.1

202

596

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.5

33.0

159

394

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

33.0

203

602

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

33.0

1089

6341

SPAT1060

SPAT

Administration of oxygen

6.1

32.9

133

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.4

32.8

167

433

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

32.7

854

4694

40199

ICD-8 Finland

Essential benign hypertension

2.8

32.7

215

666

-50

ICPC

Medication/prescr/renewal

1.9

32.6

528

2509

H3600, E103

ICD-10 Finland

3.6

32.5

153

372

349

Kela drug reimbursment

Febuxostat

6.5

32.5

119

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

32.4

1368

8410

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

5.4

32.3

101

164

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.7

32.3

114

212

M05BA04

ATC

alendronic acid; oral

1.6

32.3

981

5601

GBB00

NOMESCO Finland

Tracheostomy

3.1

32.3

186

528

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

32.3

782

4212

A07AA02

ATC

nystatin; oral

1.7

32.2

765

4096

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

4.9

32.2

109

194

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.5

32.2

160

407

U04

ICPC

Incontinence urine

1.9

32.1

529

2529

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

32.1

256

889

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

50.0

32.1

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

15.1

32.1

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

15.8

32.0

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10380

52646

1.67

323.01

3.2

2.6

55.4

60.2

u/l

12.07

9724

48063

(3026782) Osmolality of Urine

7538

35088

1.75

320.83

3.8

2.8

510.4

560.6

mosm/kgh2o

88.20

6636

29599

(3043409) Potassium [Moles/volume] in Arterial blood

1887

5115

2.77

319.82

6.4

3.9

4.0

3.9

mmol/l

10.79

1756

4817

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2110

6124

2.60

313.39

2.7

2.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10941

53913

1.76

307.65

2.7

2.1

241.8

220.0

u/l

0.68

10288

50160

(3018405) Lactate [Moles/volume] in Arterial blood

2258

5924

2.90

307.65

5.8

3.8

1.5

1.4

mmol/l

3.23

2210

5826

(3003434) Protein [Mass/volume] in Pleural fluid

1534

2003

5.77

307.65

1.6

1.4

26.8

36.6

g/l

118.86

1312

1856

(3014007) Fractional oxyhemoglobin in Arterial blood

3913

10845

2.86

307.65

13.0

8.1

92.5

94.2

41.45

3893

10814

(3002582) Erythrocytes [#/volume] in Urine

10603

53742

1.68

307.65

4.6

3.3

150.2

96.9

e6/l

1.54

8757

41188

(3018418) pH of Serum or Plasma

10693

51774

1.79

307.65

6.6

3.9

7.4

0.40

2428

9544

(3018010) Neutrophils/100 leukocytes in Blood

14264

74654

1.77

307.65

7.7

5.8

62.8

57.7

307.65

13513

68916

(3013115) Eosinophils [#/volume] in Blood

15607

81503

1.86

307.65

7.6

5.9

0.2

e9/l

1.70

13824

70044

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9204

21436

4.12

307.65

3.8

2.3

19.7

23.0

83.61

8009

17929

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18215

51326

5.49

307.65

6.1

2.3

3371.6

888.3

ng/l

307.65

17085

43505

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6504

18871

2.93

307.65

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6505

18922

2.92

307.65

2.2

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3646

8890

3.24

307.65

12.2

8.3

24.6

24.2

mmol/l

5.19

3354

8288

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2376

6912

2.61

307.65

1.4

1.5

14.5

16.1

u/ml

0.14

175

(3006315) Basophils [#/volume] in Blood

15324

79108

1.88

307.65

7.2

5.7

0.0

e9/l

0.05

13479

67027

(3020891) Body temperature

2410

6778

2.71

307.65

7.4

4.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15337

75148

2.04

307.65

6.9

4.6

32.7

35.1

g/l

307.65

14399

69071

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3907

10835

2.85

307.65

12.7

8.0

1.5

1.3

14.20

3880

10760

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6572

20248

2.75

307.65

4.7

4.2

262.7

243.7

u/l

14.67

6227

19072

(3022217) INR in Platelet poor plasma by Coagulation assay

8160

23442

3.13

307.65

41.4

23.8

1.8

1.4

inr

61.28

952

3297

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5489

15489

2.93

307.65

3.2

2.2

10.0

7.0

ug/l

8.87

4813

13338

(3027456) Digoxin [Moles/volume] in Serum or Plasma

3004

2351

10.18

307.65

3.4

2.8

0.8

nmol/l

5.63

2406

1728

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17260

87239

2.11

307.65

8.0

6.3

13.7

11.9

umol/l

46.51

16595

82514

(3013826) Glucose [Moles/volume] in Serum or Plasma

18785

100537

2.06

307.65

9.3

4.4

7.3

6.8

mmol/l

151.33

18131

94338

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6037

15542

3.29

307.65

5.9

3.4

6.0

5.8

kpa

44.72

5837

15142

(3002030) Lymphocytes/100 leukocytes in Blood

14513

75841

1.79

307.65

8.0

6.0

21.7

27.1

307.65

13710

69666

(3027273) Bicarbonate [Moles/volume] in Venous blood

2936

8504

2.66

307.65

5.5

3.1

25.4

25.1

mmol/l

2.56

2847

8271

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4056

12040

2.67

307.65

1.9

1.6

—

(3024928) Oxygen saturation in Venous blood

1533

3314

3.46

307.65

4.4

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1952

4776

3.09

307.65

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2897

6967

3.22

307.65

2.2

1.9

2.8

2.2

ug/l

0.60

2595

6053

(3026493) Urate [Moles/volume] in Serum or Plasma

9758

44146

1.91

307.65

4.0

2.7

4429.4

5808.9

umol/l

2.16

8412

37388

(3012501) Base excess in Blood by calculation

1675

3620

3.48

307.65

6.6

3.4

3.1

2.4

mmol/l

13.40

1225

2442

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3922

10778

2.88

307.65

13.0

8.1

0.6

0.7

9.29

3896

10709

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2570

7989

2.45

307.65

6.1

3.6

48.6

47.4

1.56

2529

7906

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15006

66683

2.34

307.65

7.0

3.4

109.2

62.7

ng/l

2.95

12802

50056

(3036782) Glucose [Moles/volume] in Pleural fluid

950

1387

5.07

307.65

1.4

1.3

7.2

5.8

mmol/l

30.01

896

1271

(3019309) Folate [Moles/volume] in Red Blood Cells

8189

35631

1.93

307.65

2.0

1.7

1234.6

1139.7

nmol/l

13.46

6424

26107

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1877

4757

2.97

307.65

2.0

1.6

—

(3023368) Bacteria identified in Blood by Culture

13572

48020

3.02

307.65

6.3

4.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7672

21379

3.18

307.65

9.1

5.2

1.1

1.0

mmol/l

140.09

7191

19706

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2735

8134

2.57

307.65

4.4

2.5

1.3

1.2

9.32

2719

8095

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9106

27562

3.05

307.65

2.4

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

16700

92071

1.76

307.65

10.4

9.0

5.0

4.2

e9/l

222.27

14872

79344

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7295

26934

2.29

307.65

3.3

1.9

31.7

29.6

103.25

7072

26155

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2169

5623

2.93

307.65

2.7

3.4

6.8

4.4

ratio

0.31

170

414

(3019069) Monocytes/100 leukocytes in Blood

14406

74327

1.82

307.65

8.1

6.2

9.1

8.9

7.25

13680

68709

(3003396) Base excess in Arterial blood by calculation

7278

19399

3.30

307.65

9.9

6.5

1.5

0.9

mmol/l

19.05

5870

15269

(3019060) Gas panel - Arterial blood

4633

11023

3.43

307.65

5.9

4.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3733

12681

2.29

307.65

2.2

2.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1728

4294

3.02

307.65

2.8

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13974

59771

2.37

307.65

4.3

2.6

181.3

163.0

ug/l

3.35

13072

53736

(3028626) Oxygen [Partial pressure] in Capillary blood

1844

3505

3.98

307.65

4.2

3.0

7.8

8.1

kpa

12.45

1734

3231

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1653

3673

3.38

307.65

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3562

9397

2.98

307.65

1.7

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

1708

3632

3.54

307.65

6.6

3.4

8.1

8.6

kpa

18.63

1671

3543

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3152

9461

2.58

307.65

14.7

8.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1677

3620

3.48

307.65

6.6

3.4

5.1

5.0

kpa

6.04

1640

3532

(3034860) Kappa light chains.free [Mass/volume] in Serum

2214

5807

2.89

307.65

2.7

3.5

72.3

68.2

mg/l

0.13

1783

4701

(3012544) pH of Venous blood

6189

16183

3.25

307.65

5.9

3.4

7.4

0.92

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3555

7749

3.64

307.65

1.8

1.6

g/l

0.10

3056

6555

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4158

10493

3.18

307.65

5.8

3.2

5.3

5.1

kpa

22.54

3906

9581

(3002032) Base excess in Venous blood by calculation

6015

15524

3.28

307.65

6.0

3.4

2.2

1.7

mmol/l

12.24

5029

12609

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4012

9968

3.22

307.65

5.7

3.2

2.5

1.5

mmol/l

32.12

3108

7311

(3023199) Leukocytes [#/volume] in Pleural fluid

1337

1794

5.58

307.65

1.6

1.4

2456.5

3421.9

e6/l

0.55

982

1306

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9006

33663

2.37

307.65

6.8

3.4

681.9

468.9

ng/l

1.33

8453

27919

(3012441) Differential panel - Pleural fluid

1171

1550

5.63

307.65

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

11098

52286

1.88

307.65

4.1

3.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1226

1630

5.62

307.65

1.5

1.4

54850.5

64560.6

e6/l

0.37

747

985

(3019198) Lymphocytes [#/volume] in Blood

15449

80601

1.85

307.65

7.4

5.7

1.7

1.9

e9/l

36.14

13720

69474

(1616796) Gas panel - Central venous blood

1771

3497

3.82

307.65

5.6

3.1

—

(3042936) Bacteria identified in Isolate by Culture

6790

23102

2.47

307.65

2.7

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4349

15678

2.18

307.65

2.2

0.2

g/l

65.36

3927

14538

(3014576) Chloride [Moles/volume] in Serum or Plasma

6520

22240

2.45

307.65

10.8

6.3

103.6

104.5

mmol/l

34.16

6354

21763

(3022948) Iron [Moles/volume] in Serum or Plasma

9871

24842

3.88

307.65

3.7

2.3

11.1

12.9

umol/l

105.47

9301

22696

(3007853) Bacteria identified in Skin by Aerobe culture

5336

18613

2.31

307.65

2.4

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8227

32447

2.17

307.65

2.9

1.6

1.5

1.4

mg/l

1.18

6783

25067

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5705

16206

2.93

307.65

11.3

7.2

119.0

121.4

g/l

12.40

5570

15593

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3729

9946

2.96

307.65

10.7

6.4

24.9

24.7

mmol/l

2.22

3690

9856

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3370

5353

5.02

307.65

4.0

2.7

0.3

0.4

u/ml

0.93

2152

2920

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1972

4051

3.69

307.65

4.3

2.7

25.1

24.6

mmol/l

4.78

1762

3542

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7317

19397

3.32

307.65

9.9

6.5

5.2

5.1

kpa

10.68

6949

18522

(3004119) Hemoglobin [Mass/volume] in Venous blood

3467

10606

2.54

307.65

5.3

3.0

122.1

129.4

g/l

55.65

3365

10361

(3024354) Oxygen [Partial pressure] in Venous blood

4718

12993

2.94

307.65

4.9

2.9

4.6

4.5

kpa

0.66

4519

12617

(3027801) Oxygen [Partial pressure] in Arterial blood

7312

19385

3.32

307.65

9.9

6.5

10.5

12.6

kpa

232.53

6928

18508

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11722

41475

2.78

307.65

3.0

2.1

3.5

2.9

mg/l

84.34

10417

34643

(3014111) Lactate [Moles/volume] in Serum or Plasma

5347

14919

2.95

307.65

10.3

6.2

1.5

1.3

mmol/l

11.25

5114

14386

(3000991) Gas panel - Venous blood

5420

13957

3.23

307.65

12.0

7.4

—

(3045788) Cell count panel - Pleural fluid

1034

1374

5.59

307.65

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2215

5797

2.90

307.65

2.7

3.5

56.9

43.3

mg/l

1.42

1776

4705

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3389

7499

3.56

307.65

6.1

3.8

24.2

24.0

mmol/l

1.80

3040

6729

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3779

10695

2.78

307.65

10.0

6.5

24.8

24.6

mmol/l

2.13

3596

9933

(3021901) Oxygen saturation in Capillary blood

1561

2897

4.05

307.65

3.8

2.5

—

(3000850) Epithelial cells [#/volume] in Urine

7990

37339

1.76

307.65

3.6

2.6

5.3

4.7

e6/l

3.59

7176

32463

(3016502) Oxygen saturation in Arterial blood

6598

17469

3.25

307.65

10.3

6.9

94.1

96.0

75.48

6364

16826

(3022313) Gas panel - Capillary blood

2865

7591

2.91

307.65

6.2

3.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6498

20305

2.70

307.65

2.8

2.4

2.0

1.7

61.06

5855

17684

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

986

1427

5.12

307.65

1.4

1.3

335.5

591.1

u/l

2.09

935

1352

(40767503) Oxygen content in Capillary blood by calculation

1580

3480

3.40

307.65

3.6

2.2

15.4

16.4

13.74

881

1810

(40768806) Pleura Pathology biopsy report

1101

1631

5.02

307.65

1.6

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1524

3470

3.29

307.65

1.5

1.3

—

(3022096) Basophils/100 leukocytes in Blood

14087

71865

1.83

307.65

7.7

5.9

0.6

0.7

35.93

13367

66271

(3032080) INR in Blood by Coagulation assay

16848

73345

2.65

307.65

20.6

8.3

1.6

1.3

inr

120.43

4905

19787

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8475

26748

2.84

307.65

4.6

3.2

0.8

mmol/l

0.90

7960

24721

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6525

14371

3.96

307.65

5.0

2.2

451.1

121.2

ng/l

255.87

6180

13075

(3010421) pH of Blood

1867

4183

3.37

307.65

6.6

3.4

7.4

3.01

1643

3533

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9497

22910

4.01

307.65

3.7

2.3

g/l

0.47

8952

20890

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1524

3469

3.29

307.65

1.5

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6630

14445

4.02

307.65

12.0

6.0

13.5

9.5

mmol/l

237.06

6317

13648

(3001604) Monocytes [#/volume] in Blood

15244

78617

1.87

307.65

7.2

5.6

0.7

0.6

e9/l

112.52

13395

66543

(3006504) Eosinophils/100 leukocytes in Blood

14341

73923

1.82

307.65

7.8

5.9

2.6

2.9

35.70

13596

68092

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3949

12663

2.45

307.65

5.6

3.6

135.2

86.0

ng/l

102.85

3449

10642

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17054

87852

2.02

307.65

12.7

6.3

1.2

mmol/l

277.11

14497

73447

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2658

7974

2.55

307.65

4.4

2.5

0.7

0.50

2586

7629

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15868

79909

2.00

307.65

11.6

5.6

1.2

mmol/l

276.33

14775

71373

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2307

6690

2.62

307.65

7.0

3.5

25.2

24.7

mmol/l

6.49

2177

6083

(3023520) Reticulocytes [#/volume] in Blood

5003

15388

2.63

307.65

2.9

2.5

73.9

67.1

e9/l

26.54

3888

11696

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2318

6027

2.93

307.65

3.2

2.1

544.1

607.0

ug/l

0.29

2237

5661

(3020630) Protein [Mass/volume] in Serum or Plasma

4861

14858

2.64

307.65

2.3

2.6

64.5

66.6

g/l

54.65

4464

13291

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1586

3559

3.34

307.65

1.7

1.6

—

(3009343) pH of Capillary blood

4115

10359

3.18

307.65

5.8

3.2

7.4

4.56

636

1299

(42870588) Differential panel, method unspecified - Blood

11635

55712

1.86

307.65

7.3

5.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3468

10568

2.55

307.65

2.1

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1567

3253

3.61

307.65

2.7

2.5

32.9

33.7

umol/l

0.50

1327

2710

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1634

4182

2.92

306.90

3.6

2.3

3.7

3.6

g/l

1.42

1563

4003

(3022806) Fractional oxyhemoglobin in Capillary blood

1036

1979

3.87

305.33

2.3

1.7

88.5

89.6

4.99

1023

1948

(3021960) Folate [Moles/volume] in Serum or Plasma

8713

42765

1.68

302.16

1.8

1.5

18.9

20.5

nmol/l

17.08

7721

35775

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1104

2230

3.67

301.13

7.6

5.9

12.1

11.9

mg/l

0.48

1004

2035

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9689

48924

1.65

301.04

3.6

3.2

42.9

35.2

u/l

4.14

9163

45952

(3028271) Lactate [Moles/volume] in Capillary blood

1194

2557

3.47

299.12

2.5

1.7

mmol/l

0.28

1175

2489

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1240

2726

3.38

298.60

1.7

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

10320

53061

1.63

297.68

3.6

2.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

759

1179

4.73

289.12

1.4

1.3

11.1

14.9

u/l

2.92

662

1120

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1569

4086

2.87

285.30

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

9708

49574

1.63

284.33

4.4

3.2

0.8

0.4

e6/l

20.80

7894

37290

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1027

2089

3.63

277.12

1.6

1.5

—

(3018095) Leukocytes [#/volume] in Urine

11437

61125

1.59

274.77

5.2

3.8

135.4

111.2

e6/l

1.24

9092

44014

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1839

5315

2.59

274.35

1.6

178.9

292.0

titre

1.36

251

(3035880) pH of Pleural fluid

611

831

5.39

268.76

1.4

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

18371

109959

1.59

266.90

6.6

4.7

1124.5

1522.0

e6/l

0.61

346

1689

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4367

18135

1.87

264.16

2.8

10.0

9.7

umol/l

0.46

3852

15863

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1445

3779

2.85

260.29

1.6

1.5

—

(36304419) Bacteria [Presence] in Urine

9241

47423

1.60

259.16

4.4

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2206

7132

2.33

258.86

2.5

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1440

3770

2.84

258.86

2.1

1.9

12.8

11.3

mg/l

3.12

1333

3461

(3017143) Hepatitis C virus Ab [Presence] in Serum

3312

12603

2.01

258.43

2.0

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1176

2748

3.17

256.75

1.5

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4281

17881

1.85

253.32

5.5

3.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1455

3894

2.78

251.10

3.1

2.0

124.7

129.8

g/l

8.81

1116

2761

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1574

4395

2.67

250.71

1.4

1.5

10.8

15.7

iu/ml

1.14

106

(3020682) Albumin/Creatinine [Ratio] in Urine

10853

58160

1.56

250.53

4.8

4.0

23.3

7.3

mg/mmol

69.35

7777

36102

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1467

3950

2.77

250.32

4.2

3.1

2.2

1.5

mg/l

106.13

1327

3570

(3033658) Prothrombin time (PT) actual/Normal

8452

42772

1.61

248.82

6.5

3.9

72.3

88.2

307.65

8257

41810

(3012516) Albumin [Mass/volume] in Urine

10350

55077

1.56

244.75

3.9

3.2

402.6

408.9

mg/l

0.05

7618

34394

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1059

2389

3.28

244.41

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3386

13286

1.95

241.08

2.0

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8088

40762

1.60

240.42

3.4

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2040

6579

2.33

240.10

2.3

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1923

6119

2.35

233.05

1.9

1.8

35.3

39.3

u/l

10.04

1493

5341

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

966

2133

3.34

230.37

1.5

1.4

—

(40758558) Short blood count panel - Blood

7967

40344

1.59

230.01

8.1

7.0

—

(3009508) Creatinine [Moles/volume] in Urine

10409

56132

1.53

226.91

3.8

3.2

6.6

7.5

mmol/l

94.36

8643

46257

(3028026) IgM [Mass/volume] in Serum or Plasma

2390

8474

2.13

223.33

1.9

2.0

1.2

1.4

g/l

3.03

2194

7588

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13103

74494

1.50

220.40

2.5

2.0

90.3

94.4

pmol/l

19.47

7613

38290

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

663

1174

4.14

215.34

1.5

1.4

14.6

12.3

u/l

9.77

636

1128

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20558

128799

1.57

215.24

11.3

7.5

87.8

79.5

u/l

84.86

19748

120316

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1454

4225

2.56

213.32

3.9

2.1

85.7

88.9

5.27

1402

3945

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

827

1733

3.51

213.26

1.7

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1363

3839

2.63

212.77

4.1

2.2

224.4

199.2

17.72

1306

3628

(3037756) Immunofixation for Serum or Plasma

1379

3908

2.62

212.69

1.5

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2074

7119

2.18

209.71

2.1

2.3

3.9

3.8

g/l

0.63

1519

4957

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2078

7145

2.18

209.21

2.1

2.3

7.7

7.4

g/l

5.24

1561

5184

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2075

7139

2.18

208.57

2.1

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3652

15395

1.81

206.16

2.0

1.5

—

(3042733) HLA Ab [Presence] in Serum

360

369

7.10

205.76

5.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

423

521

5.92

205.21

37.8

33.3

7.4

7.2

ug/l

0.72

386

463

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2135

7511

2.13

202.74

7.0

4.7

1.8

1.6

10.68

2016

7062

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1961

6675

2.20

202.14

2.0

2.4

10.3

10.2

g/l

0.28

1676

5433

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3245

13266

1.86

201.74

2.2

2.4

376.7

378.5

nmol/l

0.15

2969

12144

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2184

7779

2.11

200.84

3.5

3.2

4.1

4.4

pmol/l

28.46

1972

6792

(3005719) IgG [Mass/volume] in Serum or Plasma

2811

10977

1.94

200.69

2.7

2.8

10.8

10.6

g/l

0.91

2603

9983

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

929

2216

3.09

195.50

1.5

1.4

—

(3036489) Thrombin time

1687

5475

2.30

194.51

3.4

1.8

22.9

21.7

5.29

1573

4863

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1129

3021

2.76

194.11

7.9

5.1

1504.4

1133.6

iu/ml

0.19

235

465

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13292

77019

1.46

193.23

5.7

4.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2084

7407

2.11

192.40

7.2

4.7

0.9

2.73

1969

6958

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1923

6686

2.15

187.63

2.1

2.4

3.3

3.0

g/l

19.49

1536

5059

(3047181) Lactate [Moles/volume] in Blood

1631

5302

2.29

187.15

8.4

5.7

1.4

1.3

mmol/l

5.72

1466

4668

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1146

3152

2.69

186.96

1.2

81.8

159.4

titre

0.92

(3019230) Fractional oxyhemoglobin in Venous blood

1056

2820

2.76

182.10

4.7

2.6

64.3

64.1

0.09

1049

2807

(3022493) Free Hemoglobin [Mass/volume] in Plasma

420

586

5.22

179.77

15.1

1.4

632.1

1590.9

mg/l

0.51

332

400

(3037522) Nuclear Ab [Titer] in Serum

4076

18417

1.69

178.63

1.4

1.3

493.9

530.1

titre

0.63

952

3909

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1158

3318

2.58

174.18

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1135

3220

2.60

174.14

1.3

1.2

—

(44806118)

733

1628

3.30

172.88

1.6

1.5

—

(44790048)

733

1629

3.30

172.71

1.6

1.5

—

(44790049)

733

1629

3.30

172.71

1.6

1.5

—

(44790047)

733

1629

3.30

172.71

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

625

1249

3.66

172.42

1.7

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1748

6074

2.14

170.31

2.2

2.6

0.7

1.1

g/l

3.52

1503

5065

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1565

5223

2.22

168.36

2.0

2.4

0.0

g/l

0.23

1423

4712

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1287

3955

2.41

167.15

1.7

1.5

0.2

g/l

0.00

1226

3720

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

389

544

5.20

166.10

1.5

1.3

66.0

61.5

1.35

305

450

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1309

4090

2.37

163.86

1.7

1.5

1.1

1.2

g/l

3.87

1250

3868

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1468

4884

2.23

158.91

2.0

2.4

0.0

g/l

0.56

1329

4394

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1445

4796

2.23

157.28

2.0

2.5

0.0

g/l

0.00

1326

4377

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

883

2320

2.80

156.68

3.5

2.6

2300.3

5261.3

u/ml

0.37

156

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1598

5567

2.13

154.29

1.9

2.3

35.1

37.7

g/l

47.59

1399

4637

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

964

2686

2.64

153.03

1.2

1.4

41.1

38.8

u/l

0.20

854

2292

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

939

2611

2.64

149.62

1.8

1.4

—

(3021589) Normoblasts [#/volume] in Blood

12019

70587

1.40

146.07

16.9

9.7

0.0

e9/l

1.70

9961

57660

(3017817) Protein [Mass] in Urine collected for unspecified duration

652

1503

3.17

144.86

2.1

2.4

0.4

0.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

18071

113843

1.40

143.40

6.3

4.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

921

2611

2.59

141.19

1.7

1.4

17.6

17.3

u/ml

0.02

(21494890) Protein electrophoresis panel - 24 hour Urine

742

1880

2.89

140.48

1.8

2.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

10182

58527

1.40

137.88

3.7

3.4

2.3

2.4

mmol/l

54.22

8724

49873

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

846

2328

2.67

137.47

1.8

1.4

121.0

116.3

u/ml

0.38

176

518

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2067

8262

1.86

135.07

1.5

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

327

472

5.03

135.00

1.5

1.3

2.4

2.8

0.35

262

401

(3010375) cycloSPORINE [Mass/volume] in Blood

372

604

4.48

134.37

28.8

28.9

110.5

114.3

ug/l

0.47

278

525

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3284

15040

1.65

133.49

2.8

2.5

41.7

51.4

u/l

0.63

2789

12847

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5573

28893

1.48

130.93

3.9

3.0

2.8

2.2

e6/l

3.56

3290

15865

(3023383) Lactate [Moles/volume] in Pleural fluid

328

490

4.86

130.41

1.4

1.3

2.8

3.9

mmol/l

6.80

299

449

(3011335) Digoxin [Mass/volume] in Serum or Plasma

150

13.07

129.13

2.4

2.1

—

(3004451) EKG impression Narrative

432

818

3.84

128.38

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

786

2158

2.67

128.23

2.2

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

792

2188

2.65

127.66

1.4

1.2

297.5

279.4

u/ml

0.90

539

1339

(3052851) Hemolysis interference index of Serum or Plasma

1430

5130

2.06

127.37

5.1

3.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

375

648

4.21

125.55

2.2

2.1

87.1

97.3

4.86

369

611

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

823

2348

2.57

124.46

1.4

1.2

—

(3024932) HLA-DR beta [Type]

289

403

5.20

123.82

1.0

1.1

—

(3014891) Appearance of Pleural fluid

190

166

8.29

123.13

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

1572

5907

1.97

123.13

3.3

3.1

0.5

0.3

g/l

7.33

841

2492

(3013512) EKG study

9246

53073

1.38

122.00

6.9

4.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

608

1492

2.98

121.67

1.8

1.9

2.5

0.9

g/24h

1.19

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

394

8733

0.31

121.11

1.6

1.9

—

(3003181) Sodium [Moles/volume] in Urine

1009

3209

2.31

120.86

1.5

1.3

57.3

63.7

mmol/l

5.41

792

2581

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6923

37916

1.42

119.95

1.8

1.7

17247866.7

31614609.6

pmol/l

1.63

5711

30325

(3024471) HLA-A [Type]

290

418

5.03

119.94

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

634

1609

2.88

119.62

3.7

2.6

—

(3017569) Oxygen content in Arterial blood

396

741

3.89

119.59

2.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

576

1385

3.03

119.32

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

576

1385

3.03

119.32

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

576

1385

3.03

119.32

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5862

31206

1.45

118.42

3.6

2.8

1.3

1.2

e6/l

0.28

3550

18045

(40760892) CBC W Ordered Manual Differential panel - Blood

5964

31868

1.44

118.03

5.8

4.6

—

(3039000) Anion gap in Blood

1149

3919

2.16

116.40

9.6

6.4

11.7

11.1

mmol/l

5.98

1054

3528

(3018572) Chloride [Moles/volume] in Blood

1149

3919

2.16

116.40

9.6

6.4

104.2

105.1

mmol/l

6.56

1054

3528

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

269

372

5.24

116.28

1.5

1.3

20.9

22.7

0.36

216

319

(3042631) Mycobacterium sp identified in Specimen

852

2554

2.44

116.25

2.5

2.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

195

190

7.43

116.23

1.7

1.4

116.0

115.2

ug/l

0.03

158

154

(3034770) Mitochondria Ab [Titer] in Serum

1085

3623

2.20

115.82

1.2

927.4

910.7

titre

0.03

110

(3000919) Neutrophils/100 leukocytes in Pleural fluid

283

429

4.79

110.73

1.5

1.3

19.2

22.1

0.81

247

390

(3040151) Glucose [Moles/volume] in Capillary blood

697

1941

2.62

110.54

9.5

9.1

7.6

7.4

mmol/l

0.98

587

1594

(21494755) Public health laboratory ask at order entry panel

319

7500

0.30

109.54

1.3

1.4

—

(3019977) pH of Arterial blood

431

914

3.43

109.02

2.7

2.6

7.4

0.17

162

328

(3007566) Smooth muscle Ab [Titer] in Serum

1074

3661

2.16

108.88

1.2

141.2

127.1

titre

0.18

106

283

(3017181) Myelocytes/100 leukocytes in Blood

3020

14210

1.59

108.47

4.5

3.9

1.0

0.31

1139

4177

(3006576) Bicarbonate [Moles/volume] in Blood

324

561

4.19

108.24

7.6

5.9

25.2

25.0

mmol/l

0.38

287

503

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10955

65458

1.34

107.47

2.7

2.2

76.1

79.5

nmol/l

25.62

9715

57014

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

463

1045

3.23

106.38

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

805

2449

2.41

106.35

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3094

14712

1.58

106.13

6.6

3.6

1.2

mmol/l

58.34

2859

12618

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

993

3339

2.18

104.08

1.4

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1221

4447

2.02

104.02

2.5

2.4

203.5

99.9

ug/min

6.89

741

2537

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

820

2549

2.35

103.30

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

862

2744

2.30

102.90

5.8

2.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

478

1125

3.09

102.63

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

437

978

3.25

101.77

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

928

3063

2.22

101.74

1.4

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

468

1099

3.10

100.86

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

409

907

3.28

96.64

1.6

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

500

1256

2.90

96.06

1.8

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

408

910

3.26

95.54

1.6

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2718

12866

1.58

94.36

4.3

3.8

0.8

0.6

1.27

831

3006

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

572

1563

2.67

94.10

1.6

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

2822

13489

1.56

93.89

4.6

3.9

0.1

2.45

1057

3872

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

756

2370

2.33

93.40

2.3

2.2

31.8

32.9

8.46

746

2357

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

276

474

4.22

93.20

2.0

1.8

20526.0

6770.1

e6/l

1.24

168

245

(3044927) Protein electrophoresis panel - Urine

649

1902

2.49

92.79

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

275

474

4.21

92.44

1.3

36.1

427.9

ug/l

3.78

138

268

(3041918) Cholesterol [Moles/volume] in Pleural fluid

209

285

5.31

91.75

1.3

1.1

1.3

1.8

mmol/l

6.44

123

175

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

590

1671

2.57

90.46

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

179

216

6.00

88.68

1.6

1.3

11.3

11.8

0.07

109

(3044242) Glucose [Moles/volume] in Arterial blood

361

781

3.36

88.65

2.2

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

294

554

3.85

88.04

2.1

2.0

1251.7

5632.5

e6/l

1.24

224

366

(1761868) Lipid panel - Serum or Plasma

5136

47749

0.72

87.85

3.8

3.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

580

1660

2.55

87.07

1.2

54.9

68.3

u/l

1.85

393

1098

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

213

5502

0.27

86.56

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

164

185

6.41

86.44

1.4

1.3

20.4

27.9

1.52

125

144

(3026692) Albumin [Mass/volume] in Peritoneal fluid

235

378

4.50

85.96

1.4

17.1

11.6

g/l

14.88

200

275

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1205

4683

1.89

84.87

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

439

1102

2.90

84.47

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

240

399

4.36

84.39

9.3

7.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

431

1081

2.90

83.06

1.5

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

12747

79541

1.28

82.75

5.1

3.8

0.0

estimate

0.80

2815

14450

(40761535) Cells panel - Urine sediment

2986

14937

1.49

79.64

4.5

3.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

157

187

6.07

78.78

1.3

1.2

339.6

233.6

u/l

0.13

147

(3025159) Blasts/100 leukocytes in Blood

2594

12626

1.53

78.75

4.6

3.9

0.1

0.3

2.37

910

3272

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

583

1756

2.42

78.66

3.5

3.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

168

216

5.62

78.33

1.3

1.2

1.1

1.3

mmol/l

0.16

148

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2735

13485

1.51

78.13

4.1

2.7

48.1

63.8

ml/min/173m2

99.97

1460

5361

(3033799) Differential panel - Peritoneal fluid

257

480

3.88

77.93

2.3

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

12851

80632

1.27

77.91

5.2

3.9

0.0

estimate

3.04

2677

14286

(3004809) Band form neutrophils/100 leukocytes in Blood

834

2955

2.06

76.31

3.7

3.4

1.5

0.14

653

2266

(3021601) Nitrite [Presence] in Urine by Test strip

12680

79655

1.27

74.95

6.8

5.1

0.0

estimate

1.08

2833

14671

(40758047) Lysozyme [Mass/volume] in Pleural fluid

123

117

7.59

74.83

1.2

1.1

8.4

9.1

mg/l

0.21

118

108

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

142

161

6.37

74.55

1.3

1.2

6.5

203063.3

nmol/l

0.72

116

131

(3002331) Protein [Mass/volume] in Peritoneal fluid

208

341

4.41

74.43

1.5

1.3

31.0

45.4

g/l

0.36

179

251

(3051651) Icteric interference index of Serum or Plasma

377

941

2.91

73.31

6.0

3.6

—

(3025941) Bacteria identified in Stool by Culture

1737

7822

1.64

73.29

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

555

1694

2.39

72.76

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

268

543

3.58

72.61

1.8

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

327

761

3.12

71.62

1.2

1.1

3.3

3.5

iu/ml

0.08

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

205

343

4.32

71.59

2.2

1.9

229.1

188.0

4.34

200

321

(3038071) Oxygen [Partial pressure] in Mixed venous blood

203

343

4.28

70.05

9.2

7.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

239

461

3.75

69.42

2.1

1.8

183.0

166.3

1.98

222

427

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

141

172

5.92

69.22

1.5

1.3

73.3

69.4

0.55

114

145

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

223

416

3.88

67.79

6.1

5.5

68.7

71.3

0.66

188

333

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

337

827

2.96

67.54

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

337

828

2.95

67.40

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

227

438

3.75

65.93

2.2

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

18173

119954

1.26

65.92

5.5

4.1

20.5

13.1

mm/h

307.65

16869

109310

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5810

33485

1.31

65.50

3.2

2.5

mmol/l

20.57

4945

29222

(3007164) IgA [Mass/volume] in Serum or Plasma

4625

25792

1.35

65.43

1.7

1.5

3.0

2.6

g/l

22.60

2996

14347

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21045

160309

0.77

65.09

6.1

5.4

2.2

2.6

mmol/l

307.65

19313

144596

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

358

931

2.79

64.73

1.2

117.0

87.2

u/l

4.66

317

803

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

557

1796

2.26

64.50

1.4

1.2

4.3

3.8

u/ml

0.49

280

770

(3000963) Hemoglobin [Mass/volume] in Blood

23079

173571

0.75

63.64

51.1

22.3

126.9

135.2

g/l

307.65

22708

170434

(3026361) Erythrocytes [#/volume] in Blood

23076

173551

0.75

63.63

50.6

22.2

4.2

4.5

e12/l

307.65

22449

167285

(3024731) MCV [Entitic volume]

23076

173544

0.75

63.50

50.5

22.1

92.3

91.5

101.56

22692

170404

(3021788) Differential panel - Synovial fluid

825

3112

1.94

63.36

1.5

—

(3045716) Anion gap in Serum or Plasma

309

749

2.99

63.28

2.4

8.9

9.1

mmol/l

0.46

251

541

(3035941) MCH [Entitic mass]

23076

173521

0.75

63.08

50.4

22.1

30.3

30.5

45.40

22688

170392

(3010813) Leukocytes [#/volume] in Blood

23086

173565

0.75

62.71

50.7

22.2

7.6

6.8

e9/l

296.94

22458

167345

(3000494) Fungus identified in Specimen by Culture

3536

19014

1.39

62.63

1.7

1.4

—

(3007461) Platelets [#/volume] in Blood

23075

173478

0.75

62.42

50.6

22.2

232.8

242.4

e9/l

74.58

22509

167977

(3042111) Morphology [Interpretation] in Bone marrow Narrative

819

3100

1.93

62.27

1.5

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

559

1841

2.21

61.56

1.4

1.2

5.3

4.0

u/ml

0.49

208

613

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

345

907

2.76

61.16

1.2

34.7

24.8

u/l

2.43

300

766

(3036525) Urea [Moles/time] in 24 hour Urine

8.78

61.04

2.9

3.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

6582

38881

1.29

60.86

4.7

3.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

286

678

3.06

60.83

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

117

137

6.17

59.73

1.2

1.1

15.6

22.1

u/l

2.17

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

394

1124

2.54

59.62

1.2

189.6

149.1

titre

0.38

201

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

393

1123

2.54

59.28

1.2

285.7

113.2

titre

0.77

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

14791

96037

1.23

58.40

4.2

3.1

78.4

53.6

u/l

94.70

13659

87341

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

175

305

4.15

58.18

3.5

1.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

341

916

2.70

58.08

1.5

1.4

16.3

13.4

umol/l

8.60

329

856

(3051611) Lipemic interference index of Serum or Plasma

546

1830

2.17

57.62

5.7

3.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17587

116381

1.24

57.60

4.5

3.9

15.5

15.0

pmol/l

106.00

16023

103062

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20517

156257

0.79

57.56

5.4

4.8

4.0

4.5

mmol/l

307.65

18883

141520

(3000492) Spirometry study

2534

13040

1.44

57.30

1.7

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

308

792

2.82

56.90

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

7296

43951

1.26

56.72

5.8

4.3

0.0

estimate

0.88

2531

13971

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

637

2286

2.03

56.31

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

332

894

2.69

56.30

3.2

3.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

261

614

3.08

56.26

2.5

2.8

—

(3017704) Immunofixation for Urine

357

999

2.59

56.18

1.4

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20313

154758

0.79

55.88

5.4

4.7

1.3

1.4

mmol/l

307.65

18569

139109

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

310

815

2.76

55.01

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

310

815

2.76

55.01

1.5

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1019

4295

1.73

54.79

5.4

2.9

1.7

1.6

mmol/l

1.46

987

4213

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

882

3568

1.80

54.53

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1006

4239

1.73

54.14

1.7

1.6

23485.7

13475.6

e6/l

4.34

717

3075

(40761536) Microorganisms panel - Urine sediment

2605

13617

1.42

53.85

6.1

4.1

—

(40762365) Oxygen content in Arterial blood by calculation

158

271

4.21

53.63

2.2

3.6

14.8

14.7

ml/dl

0.12

145

256

(3011544) Albumin [Mass/volume] in Pleural fluid

113

145

5.63

52.92

1.2

14.8

19.3

g/l

5.87

108

126

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

200

413

3.50

52.85

1.1

—

(3025315) Body weight

100

113

6.39

52.76

5.4

4.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

313

850

2.67

52.27

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

313

850

2.67

52.27

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

313

850

2.67

52.27

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

313

850

2.67

52.27

1.8

—

(3041354) Potassium [Moles/volume] in Venous blood

655

2450

1.95

51.56

3.8

2.1

4.2

4.1

mmol/l

9.43

646

2432

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

192

393

3.53

51.40

1.2

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

654

2450

1.94

51.26

3.8

2.1

105.3

105.6

mmol/l

0.75

645

2431

(3051593) INR in Capillary blood by Coagulation assay

335

952

2.55

51.16

15.2

8.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1329

14479

0.64

50.77

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20716

157042

0.80

50.07

5.9

5.1

6.5

6.1

mmol/l

251.82

18662

140399

(3014148) Varicella zoster virus Ab [Titer] in Serum

390

1204

2.35

49.97

1.1

—

(3047189) Immunofixation for 24 hour Urine

303

834

2.63

49.32

1.5

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

147

3417

0.31

48.98

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

640

2422

1.92

48.70

3.8

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

552

1988

2.02

48.36

4.5

3.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

324

939

2.50

47.57

2.5

2.2

22.0

34.5

umol/l

0.83

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

405

1305

2.25

47.07

1.3

1.1

88.4

96.9

6.53

389

1198

(3016650) Hepatitis A virus Ab [Presence] in Serum

571

2112

1.97

46.45

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

295

828

2.58

46.24

2.4

—

(3014271) Vancomycin [Susceptibility]

351

1073

2.37

46.00

3.5

2.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

129

213

4.37

45.95

1.3

1.2

650.8

159.5

ng/l

0.41

145

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

101

135

5.40

45.46

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

309

897

2.50

45.24

2.1

1.9

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

104

144

5.21

45.14

1.2

111.0

99.1

ug/l

0.30

(3004775) Volume in Urine collected for unspecified duration

442

1505

2.13

44.92

2.4

2.2

705.6

678.1

0.57

298

981

(3016750) Collection duration of Urine

345

1059

2.36

44.82

2.2

2.1

499.4

497.9

min

0.08

248

758

(3044941) Cell count panel - Synovial fluid

666

2626

1.85

44.73

1.5

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

9.51

44.47

1.2

1.1

4970.8

1632.9

ng/l

1.60

(3012565) Volume of 24 hour Urine

288

816

2.56

44.32

2.4

2.2

1646.1

1963.3

4.41

244

711

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

956

4195

1.66

44.29

1.8

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

627

2433

1.87

44.27

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1899

9713

1.44

43.91

3.7

2.8

0.4

0.3

e6/l

2.28

1865

9547

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

480

1718

2.03

42.82

1.3

1.1

100.0

118.3

18.27

450

1516

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

406

1363

2.16

42.77

1.1

—

(3034426) Prothrombin time (PT)

177

389

3.29

42.68

1.4

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

125

214

4.22

42.63

1.5

1.1

76.5

73.4

0.30

(3001019) Free T4 and TSH panel - Serum or Plasma

210

3847

0.39

42.42

1.6

—

(4268621)

367

1188

2.24

42.24

2.6

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

573

2195

1.90

42.09

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

942

4173

1.65

42.07

1.6

10.2

4.1

iu/ml

0.45

239

985

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

338

1061

2.31

41.79

1.1

1.2

—

(3044889) 12 lead EKG panel

17432

116841

1.20

41.47

7.0

4.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.80

41.16

4.4

3.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

9.56

41.02

12.0

14.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

124

218

4.11

40.92

1.5

1.1

81.5

83.0

0.13

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

318

988

2.33

40.27

1.6

1.5

7.5

6.3

u/l

0.41

153

466

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

510

2.89

39.80

3.0

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

510

2.89

39.80

3.0

2.5

—

(3038515) Glucose [Moles/volume] in Venous blood

921

4121

1.63

39.54

5.8

3.0

8.0

7.6

mmol/l

3.40

893

4050

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

509

1922

1.92

39.05

1.1

1.7

1.5

g/l

10.50

473

1710

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5106

43651

0.81

38.76

2.8

3.2

0.8

ug/l

0.14

3659

30710

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

557

2174

1.86

38.66

1.5

1.4

—

(4306422)

480

1784

1.95

38.57

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

948

4303

1.61

38.40

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

546

2127

1.86

38.13

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

544

2118

1.87

38.06

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

953

4344

1.60

37.94

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

954

4357

1.60

37.67

1.3

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

8.02

37.61

14.5

8.8

185.8

146.4

e6/l

0.33

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

482

1810

1.93

37.60

1.3

1.1

—

(3012898) Urea [Moles/volume] in Urine

116

5.29

37.52

1.2

1.4

137.2

168.6

mmol/l

1.40

100

(3025468) Yersinia sp identified in Specimen by Organism specific culture

538

2099

1.86

37.40

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11837

77133

1.18

37.10

2.8

2.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

537

2106

1.85

36.74

1.5

1.4

—

(4010399)

2252

12213

1.36

36.62

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

221

606

2.64

36.39

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

535

2103

1.85

36.35

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

112

201

4.02

36.05

4.8

5.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

142

4.67

35.56

1.6

1.7

46.2

44.5

umol/l

0.16

142

(40768797) Stomach Pathology biopsy report

3932

23085

1.26

35.50

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

387

1372

2.04

35.50

1.6

25.1

25.5

u/ml

0.05

315

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

549

2196

1.81

35.29

1.6

1.5

69.4

58.7

8.39

354

1390

(3009871) Measles virus Ab [Titer] in Serum

150

338

3.21

34.88

1.3

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22627

168694

0.81

34.84

16.9

10.9

26.8

25.8

u/l

1.88

21937

161306

(3019225) pH of Specimen

3229

18561

1.28

34.57

7.4

4.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

235

683

2.49

34.45

1.9

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

561

2278

1.79

34.33

1.4

1.6

0.8

0.9

g/l

0.37

408

1696

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5257

44354

0.82

34.26

1.7

1.6

1.5

1.3

mmol/l

17.71

4380

36397

(3052592) Norovirus Ag [Presence] in Stool

144

320

3.25

34.24

1.4

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.64

34.06

9.5

9.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

232

678

2.47

33.64

1.9

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

126

4.81

33.55

2.7

1.8

66.2

54.8

1.59

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

469

1815

1.87

33.48

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

231

678

2.46

33.20

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

474

1852

1.86

32.86

3.5

3.4

62.8

58.5

3.06

312

1177

(3016038) Potassium [Moles/volume] in Urine

343

1197

2.08

32.85

1.2

32.5

35.6

mmol/l

1.57

295

1011

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22685

168913

0.82

32.79

42.8

17.7

104.7

80.4

umol/l

307.65

22675

168852

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9413

60754

1.17

31.36

5.8

4.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

166

425

2.82

31.16

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

195

544

2.59

31.12

1.7

20142.2

40698.0

u/ml

0.36

(3008295) Osmolality of Serum or Plasma

435

1685

1.87

31.00

1.3

275.8

277.6

mosm/kgh2o

0.65

325

1292

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

373

1373

1.97

30.91

1.9

1.8

5.6

3.9

mg/l

6.24

349

1306

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1069

5234

1.49

30.82

1.2

1.4

0.9

u/ml

0.62

105

483

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

128

283

3.26

30.73

8.0

7.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

536

2220

1.75

30.71

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

136

314

3.13

30.48

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

715

3215

1.62

30.14

2.4

1.5

1.0

0.8

nmol/l

6.73

569

2674

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

114

237

3.47

30.05

1.3

1.4

100.3

112.8

2.29

109

228

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

104

204

3.68

29.80

4.6

5.5

55.9

51.3

ug/min

0.26

169

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

421

1636

1.86

29.73

1.5

19.8

29.3

7.95

282

1003

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2551

14499

1.29

29.55

1.8

1.7

1.6

16.12

2079

12303

(3005322) IgE [Units/volume] in Serum or Plasma

1468

7687

1.39

29.48

1.3

303.9

269.2

u/ml

0.52

1360

7013

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

318

1126

2.04

29.36

1.3

132.9

62.4

titre

0.60

100

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

188

531

2.56

29.31

3.4

1.8

60.0

418.7

ug/l

1.05

178

499

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.34

28.90

5.5

6.6

441.9

445.0

umol/l

0.02

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7509

60664

0.85

28.89

4.0

4.6

22.9

22.0

5.12

3573

31740

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

324

1165

2.01

28.71

1.4

1.3

622.8

363.1

titre

0.56

106

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

654

2913

1.63

28.65

1.2

4.1

5.5

u/ml

0.33

237

(3023420) DNA double strand Ab [Units/volume] in Serum

363

1361

1.93

28.57

1.7

1.4

25.1

28.3

iu/ml

0.25

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

253

830

2.20

28.39

1.2

1.1

34.9

28.1

u/l

0.72

187

611

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

598

6846

0.62

28.16

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

663

2980

1.62

28.02

1.2

6.2

12.4

u/ml

—

(21491868) Cryoglobulin [Mass/volume] in Serum

176

494

2.57

27.81

1.3

1.2

0.3

0.9

g/l

1.12

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.93

27.57

2.6

1.8

12.1

19.9

0.96

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

250

831

2.18

27.20

1.2

1.1

103.9

87.6

u/l

1.07

190

640

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

197

595

2.39

26.75

1.5

1.7

73.7

105.2

umol/l

1.60

106

320

(3028192) IgG subclass 2 [Mass/volume] in Serum

368

1418

1.88

26.73

1.4

2.6

3.0

g/l

3.37

251

965

(3029634) Reagin Ab [Titer] in Serum by VDRL

412

1647

1.81

26.65

2.1

7.6

7.0

titre

0.03

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

228

3.35

26.61

2.2

2.7

141.0

52.4

mg/l

1.14

(3024139) IgG subclass 3 [Mass/volume] in Serum

367

1417

1.88

26.50

1.4

0.5

0.4

g/l

0.86

250

966

(3027135) IgG subclass 1 [Mass/volume] in Serum

367

1419

1.87

26.38

1.4

7.4

6.8

g/l

1.17

244

969

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

280

985

2.06

26.37

1.0

308.6

284.3

mg/l

5.63

257

867

(40768800) Prostate Pathology biopsy report

429

5226

0.58

26.08

1.1

1.2

—

(40763791) Oxygen content in Venous blood by calculation

8.83

25.98

7.3

4.1

10.9

12.6

ml/dl

0.98

(4062490)

365

1419

1.86

25.81

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

414

1683

1.78

25.36

1.5

1.3

179699.6

139075.5

e6/l

0.46

291

1160

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

282

1010

2.02

25.33

2.9

1.7

—

(21494434) Karyotype in Bone marrow

407

1647

1.79

25.32

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

331

2.86

25.28

1.2

1.1

74.1

86.9

3.71

156

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

199

621

2.32

25.17

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

5.62

24.99

1.2

0.1

g/l

1.90

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

725

3426

1.54

24.76

1.2

1.3

6.4

5.4

u/ml

0.10

374

(3003129) Base excess in Capillary blood by calculation

164

473

2.50

24.60

2.2

1.7

1.0

0.3

mmol/l

1.10

153

446

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

731

3468

1.53

24.52

1.2

1.3

7.2

5.9

u/ml

0.34

133

555

(3045142) Bone marrow Pathology biopsy report

485

2083

1.69

24.50

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3373

20237

1.23

24.26

3.1

4.2

18.1

27.1

ug/l

1.19

2851

16800

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

9.00

24.25

9.2

9.1

41.7

49.3

0.52

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

258

909

2.05

24.25

2.1

2.2

80.5

126.6

ug/min

0.70

203

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

130

337

2.78

23.99

1.2

1.1

87.5

103.4

3.37

124

311

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

155

441

2.54

23.92

1.4

19.4

15.4

pmol/l

2.17

128

360

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1468

13847

0.75

23.84

2.2

2.1

10.6

12.5

nmol/l

15.11

1219

12065

(3032057) Clostridioides difficile [Presence] in Stool

138

371

2.68

23.80

2.1

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20184

150895

0.86

23.64

33.9

14.3

64.6

76.0

ml/min/173m2

307.65

17931

124437

(3035637) Corticotropin [Mass/volume] in Plasma

445

1901

1.70

22.96

1.6

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

181

565

2.31

22.93

4.2

3.5

58.8

52.7

2.96

176

546

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

764

3717

1.49

22.78

1.2

30.3

38.9

u/ml

0.43

210

(3011412) CD3 cells [#/volume] in Blood

350

1401

1.81

22.63

2.2

2.3

0.9

1.1

e9/l

4.73

219

850

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19999

149454

0.87

22.36

5.0

4.2

1.4

1.3

mmol/l

58.24

18194

132959

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

298

1142

1.89

22.11

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

118

304

2.80

22.06

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22736

158502

1.17

22.02

36.3

14.7

27.6

26.6

mg/l

5.47

21348

127055

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

209

3.21

21.91

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

438

1888

1.68

21.89

1.2

169.9

208.0

miu/ml

0.80

634

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

565

2598

1.58

21.81

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

163

499

2.36

21.60

1.3

1.2

—

(3000012) Reticulocyte production index

283

1075

1.90

21.57

1.7

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

569

2634

1.57

21.35

1.6

1.9

21.1

24.7

ug/l

1.21

544

2586

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

356

1464

1.76

21.07

1.2

1.3

1.7

1.4

nmol/l

4.06

317

1332

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

658

3155

1.51

21.06

1.6

1.7

4.2

4.6

iu/l

0.28

200

966

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

198

3.20

20.72

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

122

332

2.65

20.63

1.2

1.1

69.0

86.8

4.32

164

(3041096) Erythrocytes [Presence] in Urine by Automated

6376

40970

1.16

20.42

5.1

3.6

—

(3003338) MCHC [Mass/volume]

16878

127279

0.88

20.38

46.3

19.9

327.5

332.5

g/l

307.65

16635

126259

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

266

1014

1.90

20.10

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.80

20.10

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

135

3.68

19.98

1.1

11.5

20.2

iu/ml

0.65

(3039162) Centromere protein B Ab [Units/volume] in Serum

382

1629

1.70

19.91

1.2

58.3

55.1

u/ml

0.08

112

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

108

282

2.76

19.76

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

202

2815

0.51

19.75

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

475

2149

1.60

19.68

1.4

89.6

60.1

mu/l

1.80

403

1901

(3019150) Specific gravity of Urine by Refractometry

5553

35428

1.16

19.44

5.8

4.3

1.0

kg/l

1.20

916

5436

(3004716) Salmonella sp identified in Stool by Organism specific culture

1059

5631

1.37

19.37

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

285

1126

1.83

19.30

1.6

1.3

1.0

1.3

promille

2.87

217

866

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.20

19.29

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

997

5258

1.38

19.19

1.4

259.0

259.6

ug/g

0.02

637

3155

(3002621) Streptococcal DNAse B [Units/volume] in Serum

129

3.69

19.16

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

168

550

2.21

19.14

1.1

379.7

170.7

iu/ml

2.13

163

545

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

104

272

2.76

18.99

1.1

4.1

10.0

pmol/l

0.41

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

364

1554

1.69

18.92

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1954

17218

0.80

18.15

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

881

1.91

18.10

4.0

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

524

5598

0.67

17.89

1.6

—

(4015189)

157

515

2.20

17.84

2.2

2.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

428

1955

1.58

17.11

1.3

—

nmol/l

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

487

2310

1.53

16.50

2.2

2.6

236.8

1424.0

u/ml

1.58

472

2276

(1175426) CD3 cells/100 lymphocytes in Blood

266

1083

1.77

16.42

1.9

2.0

72.8

69.9

1.92

248

1034

(3028433) Virus identified in Specimen by Culture

157

534

2.12

16.36

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

232

909

1.84

16.23

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

110

322

2.46

16.19

1.7

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

121

371

2.35

16.12

2.2

2.5

7.7

mmol/l

0.02

232

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

261

1063

1.77

16.10

1.9

14.3

15.6

0.59

103

428

(3024263) Appearance of Synovial fluid

227

892

1.84

15.75

1.7

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

136

446

2.20

15.54

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

236

944

1.81

15.48

2.3

2.4

423.5

561.1

e6/l

2.21

197

795

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

443

2091

1.53

15.39

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1104

10200

0.77

15.26

2.3

2.4

34.0

29.2

au/ml

0.16

377

(3027923) C peptide [Moles/volume] in Serum or Plasma

225

891

1.82

15.25

1.3

1.4

1.2

nmol/l

1.68

161

681

(3009466) Valproate [Moles/volume] in Serum or Plasma

453

2155

1.52

15.19

4.5

4.4

340.6

349.4

umol/l

0.67

386

1813

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1704

9979

1.24

15.14

2.6

2.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

333

1476

1.63

15.12

1.1

1.0

2.2

iu/ml

—

(3010503) CD19 cells [#/volume] in Blood

236

952

1.79

15.07

2.2

2.4

0.5

0.4

e9/l

0.07

223

921

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

496

2410

1.49

15.04

2.9

2.0

24.3

27.7

mg/l

0.66

129

627

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

361

1639

1.59

14.87

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

233

941

1.79

14.83

1.8

2.0

2.8

2.6

u/field

0.11

167

641

(3034891) Synovial lining cells/100 cells in Synovial fluid

208

811

1.85

14.83

1.5

3.1

4.2

0.61

171

(3036603) Volume of Urine

269

1133

1.72

14.82

1.5

1.6

1788.3

1964.4

0.87

299

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

471

2273

1.50

14.77

1.3

3.0

1.4

nmol/l

0.31

441

2173

(21494815) CD4 cells/100 lymphocytes in Specimen

291

1255

1.68

14.70

1.7

2.1

40.0

38.4

0.22

144

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

3.76

14.68

1.2

1.3

116.0

1196.7

u/l

0.79

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

471

2279

1.50

14.59

1.3

0.2

0.3

nmol/l

2.06

177

(3004616) Nuclear Ab [Presence] in Serum

395

1840

1.55

14.59

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

259

1085

1.72

14.55

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1793

15573

0.82

14.38

1.5

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

992

9208

0.77

14.22

1.2

1.3

34.4

56.9

au/ml

3.12

405

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

213

850

1.81

14.13

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1215

0.38

14.09

1.3

1.4

58.1

93.2

pmol/l

0.72

396

(3001964) Herpes simplex virus Ag [Presence] in Specimen

129

432

2.15

14.05

1.6

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

213

852

1.81

14.02

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

222

902

1.78

13.89

2.4

2.5

0.2

0.3

e9/l

4.23

197

791

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

113

362

2.25

13.71

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

491

5040

0.70

13.62

1.5

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

327

1485

1.59

13.51

2.0

2.1

2.0

2.5

u/field

0.65

141

563

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

7.54

13.44

5.7

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

883

4836

1.32

13.38

1.7

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

239

1005

1.72

13.30

2.1

1.6

73.6

73.0

umol/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

145

520

2.01

13.25

1.2

1.1

2.4

21.0

u/ml

1.30

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

251

1071

1.69

13.25

2.1

2.5

511.4

718.8

e6/l

1.08

101

432

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

419

2024

1.50

13.14

1.2

1.3

302.0

281.2

pmol/l

0.38

311

1540

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

178

2.79

13.07

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9888

75781

0.91

13.06

4.6

5.4

3.6

3.7

ug/l

0.19

8557

67692

(3048879) Bone marrow aspiration report

156

581

1.94

12.84

1.5

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

103

327

2.27

12.80

1.8

2.0

—

(37019676) Renin [Units/volume] in Plasma --supine

5.56

12.70

1.0

1.2

45.1

58.0

mu/l

0.11

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.74

12.54

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

250

2.45

12.50

1.3

1.5

—

(4281824)

334

1565

1.54

12.11

1.3

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

120

3.12

11.94

1.4

1.3

0.5

1.1

ml/s/173m2

4.02

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

296

2.29

11.93

2.2

3.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

205

2.57

11.82

2.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

499

2549

1.42

11.76

1.2

58.0

46.4

u/ml

0.67

261

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

202

2.57

11.69

2.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

160

622

1.86

11.63

2.2

1.9

77.3

55.0

ug/l

1.35

154

609

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.60

11.60

5.9

6.2

0.9

1.1

mg/l

0.65

(40768804) Tissue Pathology biopsy report

8585

65970

0.91

11.52

2.3

2.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.17

11.38

1.0

1.1

151.9

226.1

pmol/l

0.55

(3049717) Cytology report of Urine Cyto stain

1429

8474

1.22

11.32

2.6

2.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

260

1174

1.60

11.10

1.2

5.6

3.1

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

126

2.97

11.05

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.32

10.81

4.8

4.4

21.0

17.5

0.35

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

432

4346

0.71

10.75

1.6

1.7

43.6

44.1

nmol/l

0.15

412

4173

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

270

1241

1.57

10.72

1.2

38.9

40.5

u/ml

0.04

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

269

1237

1.57

10.66

1.2

65.3

84.1

u/ml

0.39

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

298

1413

1.52

10.32

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

185

782

1.71

10.23

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

273

1276

1.54

10.11

1.2

5.8

55.6

u/ml

5.06

(3022621) pH of Urine by Test strip

1815

11129

1.19

10.10

3.8

3.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

102

3.11

10.09

1.0

1.1

—

(1002224) Polysomnography panel

479

4689

0.73

10.08

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

196

2.46

10.06

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4492

29397

1.12

9.84

1.3

1.2

1.9

1.8

u/ml

0.02

1104

7191

(40761539) Cells [Type] in Urine sediment by Light microscopy

124

470

1.90

9.82

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

156

636

1.77

9.81

1.6

12.1

14.8

umol/l

0.45

119

441

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

198

863

1.66

9.80

2.3

2.8

36.4

37.0

0.11

288

(21494567) Legionella sp IgM Ab [Presence] in Serum

104

3.05

9.78

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.78

9.77

2.4

2.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

200

875

1.65

9.76

1.3

1.2

225.3

367.5

u/l

1.24

188

806

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

219

984

1.61

9.62

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

302

2.12

9.55

1.3

138.8

210.8

titre

—

(40761511) CBC panel - Blood by Automated count

22163

162644

0.90

9.50

33.7

14.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.78

9.49

1.1

1.0

5.7

5.6

mmol/l

0.08

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

142

2.69

9.48

1.3

1.8

0.7

1.2

mmol/l

0.82

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

247

2.25

9.47

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

218

983

1.60

9.45

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20467

143652

1.09

9.45

5.6

4.7

2.2

2.1

mu/l

0.10

18819

128161

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

218

984

1.60

9.41

1.1

—

(3002619) Bacteria identified in Specimen by Culture

328

2.07

9.40

1.5

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

979

1.60

9.39

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

124

478

1.87

9.36

2.1

22.1

46.3

u/l

2.32

111

441

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

163

683

1.72

9.35

3.7

2.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.41

9.26

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

216

978

1.59

9.22

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

146

596

1.77

9.18

1.2

39.5

40.0

g/l

0.14

320

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

216

980

1.59

9.14

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

132

524

1.82

9.10

1.7

2.0

—

(3000330) Specific gravity of Urine by Test strip

1535

9373

1.19

8.98

4.9

3.7

—

(3016228) CD19 cells/100 cells in Blood

151

630

1.73

8.83

1.8

2.0

7.2

8.8

0.79

145

612

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.17

8.81

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.02

8.59

6.1

5.0

—

(4094501)

494

4696

0.75

8.58

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3709

24198

1.12

8.50

1.3

45.1

39.0

iu/ml

1.11

1193

7343

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.97

8.44

3.5

2.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

146

612

1.72

8.42

1.7

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

170

746

1.64

8.28

1.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

5.40

8.27

1.1

1.0

31.5

21.1

iu/ml

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

134

556

1.74

8.03

1.4

1.3

71.8

56.6

6.56

118

471

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

498

0.29

8.02

1.3

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

102

2.82

7.89

1.1

1.2

1.1

u/field

0.58

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.64

7.87

3.6

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

179

2000

0.64

7.87

2.0

1.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

130

539

1.74

7.83

1.8

1.4

—

(4035726)

2460

15744

1.14

7.73

1.6

1.4

—

(3008898) HLA-B27 [Presence]

332

3294

0.72

7.73

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

136

1609

0.61

7.70

2.0

1.9

—

(3019174) dRVVT (LA screen)

100

2.81

7.63

1.2

—

(4146454)

415

2225

1.35

7.48

2.9

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

321

3184

0.72

7.47

1.9

180.9

197.3

pmol/l

1.99

300

2955

(3006245) CD3-CD19+ cells/100 cells in Blood

115

467

1.78

7.46

2.1

2.0

12.6

12.0

0.11

100

423

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.31

7.43

1.0

1.1

1.4

u/field

0.17

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

116

473

1.77

7.42

2.0

1.9

31.9

29.0

0.98

104

442

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

142

615

1.66

7.33

1.8

1.6

5.0

8.8

nmol/l

0.45

122

528

(4034850)

893

5285

1.22

7.33

20.3

10.5

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.26

7.26

1.3

1.4

147.5

120.5

ug/l

0.24

(3046861) Legionella sp Ag [Presence] in Urine

2.76

7.24

1.1

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

150

2.40

7.23

2.6

2.9

—

(3045414) Leukocytes [Presence] in Urine

1214

7412

1.19

7.17

2.3

1.9

—

(3006270) Folate [Moles/volume] in Blood

293

1495

1.41

7.16

1.3

1.2

299.4

336.6

nmol/l

1.91

237

1174

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

318

1.93

7.13

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

404

2176

1.34

7.09

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1144

6969

1.19

6.95

2.4

3.5

1073.0

1790.0

u/ml

0.58

951

5993

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

152

683

1.60

6.83

1.1

ratio

1.61

214

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

6.24

6.81

1.2

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23045

168280

0.92

6.71

46.8

17.3

4.1

4.0

mmol/l

243.16

22604

163619

(1761482) Bacteria [#/volume] in Urine by Culture

885

5283

1.21

6.70

5.6

4.3

—

(3017732) Neutrophils [#/volume] in Blood

1711

10791

1.15

6.70

3.6

3.1

4.8

4.1

e9/l

14.95

1189

7791

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

290

1.94

6.69

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.00

6.64

3.9

3.7

—

(3029075) Extractable nuclear Ab panel - Serum

373

1.82

6.63

1.1

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.14

6.58

1.0

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

282

1.94

6.57

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1226

10264

0.85

6.54

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

387

1.79

6.44

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

125

544

1.66

6.40

3.1

2.7

32.9

21.0

mu/l

1.42

109

507

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

150

684

1.58

6.38

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

115

1347

0.61

6.34

1.0

250.2

336.1

ng/l

5.75

907

(3020717) Zinc [Moles/volume] in Serum or Plasma

131

579

1.63

6.33

1.4

1.5

16.0

25.3

umol/l

3.95

124

551

(3001186) Copper [Moles/volume] in Serum or Plasma

291

1.91

6.32

1.1

1.2

17.8

16.1

umol/l

2.32

260

(3020393) Adenovirus Ag [Presence] in Stool

174

2.19

6.31

1.2

—

(3020491) Glucose [Moles/volume] in Blood

234

1175

1.44

6.30

2.2

1.9

8.1

7.1

mmol/l

3.29

164

789

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

297

1.89

6.27

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

108

455

1.71

6.25

2.8

2.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

117

1356

0.62

6.17

1.0

35.9

43.4

ng/l

2.13

897

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

229

2.01

6.14

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

100

2.59

6.14

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

117

1352

0.62

6.10

1.0

746.8

702.9

ng/l

0.52

875

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

220

2.03

6.09

2.3

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

394

2169

1.31

6.02

1.7

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.67

5.96

1.1

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.71

5.94

1.0

1.2

44.5

39.7

mg/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

378

0.30

5.94

1.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

23038

167955

0.92

5.38

46.4

17.2

139.1

139.6

mmol/l

150.61

22617

163547

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

331

1.76

5.28

1.3

1.2

1.0

47.3

mg/l

1.25

260

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

139

655

1.53

5.21

2.2

2.3

64.5

55.7

umol/l

1.89

525

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

764

6517

0.84

5.19

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

856

5225

1.18

5.18

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

185

2.02

5.13

4.2

2.7

1.5

1.1

mg/l

1.00

135

(3018133) Calcium [Moles/volume] in Urine

195

1.99

5.12

1.5

1.7

2.1

2.6

mmol/l

0.82

170

(3014051) Protein [Presence] in Urine by Test strip

639

3814

1.21

4.96

2.9

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

106

475

1.61

4.95

1.4

3840428.6

1282690.9

iu/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

195

994

1.41

4.95

1.8

2.0

616.0

1664.2

u/l

1.05

334

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

427

1.64

4.87

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

136

2.17

4.85

2.1

1.2

24.3

20.9

mmol/l

3.06

102

(3000034) Microalbumin [Mass/volume] in Urine

306

1681

1.31

4.85

3.3

3.0

88.2

38.4

mg/l

2.34

230

1218

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

181

916

1.42

4.79

1.2

1.4

0.9

1.6

u/ml

0.82

112

487

(4198724)

288

1.78

4.78

1.5

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

441

3930

0.80

4.74

3.7

1.6

6.8

3.5

mg/l

4.42

405

2817

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

420

1.63

4.70

1.1

1.2

523.0

268.3

pmol/l

0.73

301

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

340

0.36

4.61

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

409

1.62

4.48

2.2

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

238

1278

1.34

4.45

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.14

4.38

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

319

0.36

4.33

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

318

0.36

4.30

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

317

0.36

4.28

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

317

0.36

4.28

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

134

2.10

4.27

1.4

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.80

4.21

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

221

1.82

4.17

3.1

38.0

41.0

umol/l

0.41

187

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

356

1.64

4.15

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.20

3.98

1.3

0.8

0.6

u/field

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

301

1700

1.28

3.95

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

283

0.36

3.94

1.6

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

272

0.34

3.93

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

999

0.65

3.93

1.1

1.0

3.1

3.2

u/ml

0.01

401

(3045424) Erythrocytes [Presence] in Urine

477

2838

1.21

3.93

1.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

318

1.65

3.90

1.9

2.0

998.8

1884.0

e6/l

0.33

168

(37021550) Renin [Units/volume] in Plasma --upright

365

1.60

3.80

1.2

146.1

56.9

mu/l

2.22

265

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.51

3.79

10.3

8.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

619

3790

1.18

3.74

5.3

3.4

30.0

28.8

mg/l

0.34

462

2375

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

167

1.90

3.73

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

264

0.35

3.72

1.5

1.4

—

(40768443) Skin Pathology biopsy report

1202

7722

1.13

3.69

1.3

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.74

3.68

1.5

1.1

34.2

10.7

u/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.91

3.67

1.0

1.2

—

mmol/l

—

(3005033) Fetal Nuchal fold Thickness US

262

0.36

3.66

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

397

1.56

3.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

397

1.56

3.66

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

397

1.56

3.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

397

1.56

3.66

1.1

—

(4024509)

303

1732

1.26

3.64

1.7

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

386

2267

1.23

3.64

1.1

70.0

523.2

iu/ml

0.85

439

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.62

3.58

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

1200

0.70

3.58

1.1

1.0

1.7

2.0

u/ml

0.12

282

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

123

1249

0.71

3.55

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

18839

137715

0.95

3.54

37.1

16.5

37.0

39.2

116.66

10922

88369

(40765096) Chromosome analysis panel by Banding

110

540

1.47

3.54

1.1

—

(3025130) Human papilloma virus identified in Specimen

983

0.67

3.52

2.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

197

1857

0.76

3.49

1.3

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

168

896

1.35

3.39

1.8

1.5

7.6

5.9

u/l

0.64

140

742

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

6.40

3.37

1.1

1.0

—

(44806420)

120

607

1.42

3.32

2.2

2.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

556

0.58

3.29

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

122

1222

0.72

3.28

4.9

5.2

76.0

103.1

u/ml

0.27

350

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

223

1.71

3.27

2.4

2.9

0.5

u/field

0.02

223

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

670

4181

1.16

3.24

2.6

3.3

1581.3

656.0

u/ml

0.47

594

3797

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

258

1471

1.26

3.22

1.7

1.8

4125.7

2031.0

titre

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

263

1.64

3.20

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.32

3.17

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2945

22562

0.93

3.15

5.2

4.9

32.8

32.7

0.26

2237

14559

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

734

0.65

3.12

1.1

1.4

1.6

1.5

g/l

—

(40768793) Breast Pathology biopsy report

345

3002

0.82

3.09

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

102

1040

0.70

3.08

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

809

0.67

3.06

1.0

0.0

0.5

u/ml

1.31

228

(3023430) Cat dander IgE Ab [Units/volume] in Serum

922

0.69

2.95

1.1

1.0

3.7

3.4

u/ml

0.04

366

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.30

2.89

1.1

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

108

552

1.41

2.88

11.9

17.0

1378.1

1407.0

nmol/l

0.14

103

529

(3039744) RNA polymerase III Ab [Units/volume] in Serum

115

1.94

2.87

1.1

1.0

9.6

3.7

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

358

1.51

2.84

1.1

0.7

umol/24h

0.22

163

(3013466) aPTT in Blood by Coagulation assay

2.36

2.82

1.1

37.7

39.5

0.36

(3047007) Chlamydophila sp Ab [Presence] in Serum

279

1636

1.23

2.78

1.2

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.45

2.72

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

487

1.42

2.69

1.1

1639.5

1598.8

miu/ml

0.13

487

(3030313) Adrenal Ab [Titer] in Serum

2.25

2.69

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

206

1173

1.27

2.67

3.3

2.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

178

1626

0.79

2.58

1.2

8.6

7.7

mmol/l

3.11

131

1125

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

126

1.83

2.53

1.2

1.1

9.8

11.9

u/l

0.27

126

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

194

1106

1.26

2.52

1.2

12.2

11.9

mmol/l

0.18

366

(3020961) Endomysium IgA Ab [Titer] in Serum

887

5747

1.11

2.47

1.1

204.6

220.4

titre

0.05

137

(40768441) Liver Pathology biopsy report

201

1154

1.26

2.47

1.4

1.3

—

(3021374) Sirolimus [Mass/volume] in Blood

4.58

2.43

6.7

9.9

7.3

7.7

ug/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

184

0.39

2.41

1.1

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

408

1.43

2.40

1.7

1.6

11.1

9.3

ug/l

2.09

408

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

164

1492

0.79

2.33

1.1

—

28.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

114

1.83

2.32

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

149

832

1.29

2.31

1.5

1.6

8.5

5.7

mmol/24h

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.30

2.29

1.0

1.1

0.1

0.3

g/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3314

22708

1.06

2.27

1.3

1.2

17.0

14.4

u/ml

0.47

1073

7907

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

706

0.70

2.23

1.3

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

262

1567

1.20

2.22

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

170

1.65

2.22

4.0

5.8

—

(3006462) Nitrate [Presence] in Urine

148

833

1.28

2.18

4.3

3.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

657

1.32

2.17

1.3

48.1

61.0

0.69

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

460

1.38

2.15

1.5

1.3

27.6

35.5

1.15

306

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

261

0.52

2.13

1.9

1.6

—

(4211845)

159

906

1.26

2.13

4.1

3.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

2.12

0.0

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.54

2.10

1.0

1.5

—

1932.8

umol/l

—

(3028468) Fragments [Presence] in Blood by Light microscopy

4.32

2.05

1.0

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.97

2.01

1.7

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

204

1.55

1.99

1.6

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

424

1.38

1.99

1.6

0.4

ug/l

0.38

255

(3023323) Follitropin [Units/volume] in Serum or Plasma

257

2191

0.84

1.98

1.5

1.4

25.2

31.9

iu/l

2.72

210

1837

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

244

1472

1.19

1.94

3.4

3.7

77.3

52.1

u/ml

0.72

235

1449

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

115

0.38

1.93

7.7

5.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

727

1.28

1.93

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

116

0.37

1.93

3.8

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

155

894

1.25

1.91

2.4

2.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

152

1358

0.80

1.91

1.0

1.1

0.7

1.2

u/ml

0.61

577

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

1.90

0.0

1.0

—

164.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

128

1.69

1.89

1.2

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

193

0.48

1.88

1.0

—

(4212803)

190

1.55

1.88

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

182

1589

0.82

1.84

1.1

2.1

1.4

u/ml

0.22

656

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

100

932

0.77

1.81

1.2

1.1

39.4

46.0

mg/l

1.14

789

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3360

23178

1.05

1.81

16.2

6.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

883

0.77

1.81

1.1

262.9

319.5

mg/l

2.46

777

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.80

1.0

1.1

—

(44806071)

158

1.59

1.80

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.60

1.78

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

527

1.31

1.77

7.5

12.2

765.9

829.9

nmol/l

0.67

495

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.40

1.74

1.3

1.0

2.3

2.6

0.22

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

131

0.44

1.73

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

183

1.53

1.72

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

183

1.53

1.72

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

183

1.53

1.72

1.3

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.71

0.0

1.3

—

367.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.27

1.71

1.5

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.27

1.71

1.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

400

1.35

1.69

2.5

136.7

142.5

nmol/l

0.20

346

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.87

1.69

1.8

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.91

1.68

1.6

2.2

1.0

mg/l

—

(3015183) Erythrocyte sedimentation rate

468

0.69

1.68

1.5

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.78

1.68

1.2

1.4

1.3

1.0

u/field

0.44

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

846

0.77

1.65

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

304

1.40

1.65

3.1

4.9

40.1

54.8

u/l

0.62

104

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.85

1.63

1.8

1.6

0.3

u/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

499

3219

1.12

1.63

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

160

1394

0.82

1.63

1.0

1.1

5.0

3.1

u/ml

0.52

669

(3035611) Eosinophils/100 leukocytes in Synovial fluid

123

1.64

1.62

1.5

1.6

1.0

0.9

0.10

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

655

0.75

1.61

1.1

1.2

1.1

u/l

0.66

326

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

913

0.79

1.58

5.6

6.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.80

1.58

6.0

4.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

105

596

1.27

1.55

2.6

2.9

30.0

28.8

umol/l

0.42

446

(3028300) Cannabinoids [Presence] in Urine

227

1906

0.86

1.53

2.5

2.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.96

1.53

1.1

1.3

—

(3002256) Pathology report gross observation

2999

22453

0.96

1.51

1.4

1.3

—

(3001729) Color of Synovial fluid

149

1.55

1.49

1.4

1.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

3.0

0.8

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

1.4

2.4

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

0.3

1.2

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

0.3

1.8

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

2.1

mg/l

0.17

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

0.3

1.4

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

4.1

2.2

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

2.8

3.0

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.85

1.49

1.6

3.8

2.6

mg/l

—

(3027008) Opiates [Presence] in Urine

227

1900

0.86

1.48

2.5

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

300

0.65

1.44

1.7

—

(3027944) Amphetamines [Presence] in Urine

221

1848

0.86

1.44

2.5

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.83

1.43

1.1

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

451

1.29

1.41

1.3

1.2

38.4

21.0

0.74

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

509

1.27

1.40

1.0

1.1

99.9

98.1

0.16

388

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

712

0.78

1.39

1.1

—

(3003694) ABO and Rh group [Type] in Blood

5853

41053

1.03

1.39

1.4

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

217

1.43

1.39

1.3

7.5

6.2

mmol/l

0.56

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.71

1.38

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

652

0.77

1.35

1.0

1.1

282.9

783.8

ng/l

0.89

170

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

109

0.46

1.34

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

249

1.39

1.34

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.00

1.32

1.2

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

126

0.51

1.32

1.1

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

509

3336

1.10

1.30

1.3

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.75

1.27

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

115

1.56

1.26

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

229

1887

0.87

1.26

2.5

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

555

0.76

1.24

1.1

—

(36660697) Celiac disease serology panel - Serum

1586

10855

1.05

1.24

1.2

—

(3022145) Colonoscopy Study observation

2727

18905

1.04

1.24

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

111

654

1.22

1.24

1.4

1.6

11.3

9.3

ug/l

0.23

596

(3007463) Buprenorphine [Presence] in Urine

2.77

1.23

1.0

11.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

149

905

1.19

1.22

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

505

3329

1.09

1.17

1.1

20.9

9.2

u/ml

0.80

263

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

111

0.52

1.16

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

153

1.46

1.16

1.3

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

434

0.75

1.15

1.0

1.1

0.3

1.3

u/ml

2.62

116

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

191

1192

1.15

1.14

1.3

2.3

2.2

mmol/l

0.14

180

1108

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

854

1.18

1.11

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

265

1.33

1.10

1.3

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.00

1.10

1.0

1.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

102

1.55

1.09

1.7

1.6

202.5

ng/l

0.00

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20822

150785

0.97

1.08

8.7

6.3

44.5

40.3

mmol/mol

307.65

19288

136896

(3007919) Fasciola sp Ab [Titer] in Serum

2.19

1.07

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

168

1.41

1.07

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

127

1.47

1.04

1.2

1.0

111.8

84.1

ug/l

0.82

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

163

1.41

1.04

1.0

1.2

2.2

1.7

umol/24h

1.75

163

(42870560) Thyrotropin [Units/volume] in Cord blood

0.45

1.02

1.0

13.3

8.1

mu/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

145

896

1.17

1.01

1.2

—

(40768795) Lymph node Pathology biopsy report

266

1714

1.12

1.00

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

654

4392

1.07

1.00

1.6

1.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

6.0

—

0.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

100

1.51

0.95

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

228

1.33

0.95

1.3

1.5

—

(3007733) Chloride [Moles/volume] in Urine

1.80

0.95

1.1

95.3

82.9

mmol/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

460

0.78

0.95

1.0

1.1

0.8

1.4

u/ml

0.53

151

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

642

0.82

0.94

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.64

0.93

1.0

1.1

225.0

275.6

nmol/l

0.72

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.70

0.92

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.60

0.92

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

221

1779

0.89

0.91

2.5

2.0

—

(3020650) Glucose [Presence] in Urine

368

0.76

0.91

1.6

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.73

0.90

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.92

0.89

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

770

0.84

0.88

4.4

5.2

328.4

1439.6

u/ml

0.59

131

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

195

1.33

0.85

1.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

152

1.37

0.84

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

388

1.22

0.83

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1097

7538

1.05

0.82

1.2

103.2

132.1

iu/ml

1.94

347

2598

(3049242) von Willebrand panel - Platelet poor plasma

1.72

0.82

1.3

1.9

—

(3041184) Isoniazid [Presence] in Urine

1.88

0.80

2.5

2.7

—

(3023410) Appearance of Cerebral spinal fluid

182

1466

0.89

0.79

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.51

0.79

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

326

1.24

0.78

2.5

2.7

2532.1

1711.2

u/l

0.26

288

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

173

1.33

0.78

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

511

1.18

0.77

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

558

1.17

0.76

1.2

1.1

—

(4027681)

648

0.84

0.75

1.3

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.59

0.75

1.3

287.5

346.3

umol/24h

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

293

2294

0.92

0.74

3.4

3.6

36.6

42.1

u/ml

0.30

275

2228

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

577

0.84

0.74

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.55

0.74

1.0

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

107

1.41

0.73

1.1

14.6

nmol/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

252

1.26

0.72

1.9

1.7

62.1

56.8

pmol/l

0.13

202

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

402

1.20

0.72

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

600

4078

1.06

0.71

1.2

1.3

—

(3027874) Urate [Moles/volume] in Urine

1.56

0.70

1.1

1.3

1.7

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

603

0.85

0.69

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.57

0.68

2.9

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.62

0.68

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

432

1.18

0.67

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

197

1.28

0.67

1.0

1.1

—

(4133840)

373

1.20

0.66

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

138

0.68

0.66

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

260

0.77

0.64

1.8

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.58

0.64

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

227

0.76

0.62

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

206

1.26

0.62

1.5

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

327

2524

0.93

0.62

1.7

1.8

470.9

289.4

mu/l

0.91

299

2343

(3002523) Influenza virus A Ag [Presence] in Specimen

161

1281

0.90

0.61

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

423

0.83

0.59

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.61

0.59

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

380

1.17

0.57

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

223

0.77

0.56

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

506

3837

0.95

0.56

1.4

1.3

591.8

572.4

mg/l

0.14

487

3631

(3003740) Influenza virus B Ag [Presence] in Specimen

162

1281

0.91

0.56

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2305

16206

1.03

0.55

1.9

2.2

212.2

152.1

ug/g

4.39

1815

12508

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.51

0.55

1.2

1.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

565

0.87

0.54

14.9

12.4

0.6

0.7

mmol/l

1.06

515

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

877

1.11

0.54

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.54

0.53

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.37

0.50

1.6

1.8

1.4

umol/l

0.00

(3015076) Soybean IgE Ab [Units/volume] in Serum

352

0.84

0.50

1.0

0.8

1.9

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

200

1.22

0.49

1.2

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

312

0.83

0.48

3.1

3.2

7.7

7.3

mg/l

0.13

253

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

428

1.14

0.47

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

261

1.19

0.46

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

449

1.14

0.46

1.2

145.0

132.7

nmol/l

0.16

322

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

439

3316

0.95

0.46

1.5

673.9

2125.4

e6/l

1.40

386

2699

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.40

0.46

2.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

176

1.23

0.45

1.5

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

439

3311

0.95

0.44

1.4

12.2

34.1

e6/l

2.53

359

2565

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

431

1.14

0.44

1.2

0.3

g/l

1.71

344

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

438

1.13

0.43

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

206

0.80

0.43

2.0

2.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

433

1.13

0.42

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

166

1.21

0.40

1.8

2.7

8.7

7.3

mmol/l

1.96

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.40

0.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.44

0.39

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

253

1.17

0.39

1.0

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

403

1.13

0.37

1.2

113.1

113.7

0.07

353

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.37

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

740

1.09

0.37

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

384

1.12

0.36

5.9

6.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.35

1.0

—

(40758292) HTLV I+II Ab panel - Serum

231

0.84

0.35

1.5

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

113

0.76

0.35

2.0

2.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

148

994

1.07

0.34

1.7

2.1

15.8

16.2

nmol/l

0.26

137

922

(3017509) Phencyclidine [Presence] in Urine

1.33

0.33

1.7

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

412

3083

0.96

0.33

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

198

0.84

0.32

1.1

7.8

9.1

mg/g

0.46

186

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

124

1.22

0.32

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

690

0.92

0.32

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

936

0.93

0.32

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

191

1.17

0.32

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.72

0.31

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

526

1.09

0.31

1.6

2.1

2.0

umol/l

0.39

493

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.31

0.31

1.2

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

189

0.84

0.31

1.2

1.3

9.6

9.7

mmol/l

0.04

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

240

1.14

0.29

1.7

1.9

—

(40763590) HLA-DQ beta [Type]

1.25

0.27

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.25

0.27

1.0

—

(40760409) HLA-A [Type] by High resolution

1.25

0.27

1.0

—

(40760410) HLA-B [Type] by High resolution

1.25

0.27

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

335

2503

0.96

0.27

1.5

251.5

209.3

pmol/l

0.53

326

2434

(3022689) Creatine [Moles/volume] in Urine

510

1.09

0.27

1.5

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

107

1.21

0.27

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

587

1.08

0.26

1.0

1.1

5.3

4.8

u/ml

0.09

(3013862) HLA-DP [Type]

1.20

0.26

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

116

0.81

0.26

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

194

1465

0.95

0.26

2.4

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.25

0.26

1.6

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

208

0.86

0.25

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

118

902

0.94

0.25

1.4

1.3

32.1

30.1

u/l

0.25

725

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.23

0.24

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

315

2191

1.03

0.23

3.5

3.3

15.9

9.2

nmol/l

0.73

305

2136

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.74

0.23

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

453

3348

0.97

0.22

1.3

4.3

3.8

mmol/l

8.52

428

3144

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.22

0.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

253

1.11

0.22

1.0

1.1

0.3

1.2

u/ml

1.25

126

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

260

1.11

0.22

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

188

1411

0.96

0.21

1.9

2.1

2.3

ug/l

0.40

149

1180

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

219

1.12

0.21

3.3

3.2

68.6

150.3

ng/l

1.51

(3032641) Amino acids panel - Urine

0.00

0.21

0.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.19

0.21

1.9

1.6

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

112

0.84

0.20

1.1

1.5

8.5

14.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

407

2852

1.03

0.20

1.4

12.4

9.8

u/l

2.63

325

2262

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

807

5701

1.02

0.20

1.1

26.9

5.5

u/ml

0.43

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

193

1.12

0.19

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

401

1.08

0.19

2.0

2.2

3.5

3.4

ug/l

0.04

141

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.17

0.19

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

285

0.91

0.19

1.1

1.6

3.1

2.4

ug/l

0.38

157

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.23

0.18

1.1

1.4

229.3

571.0

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

123

926

0.96

0.17

1.0

1.1

8.5

6.7

nmol/l

0.18

192

(3011897) Casein IgE Ab [Units/volume] in Serum

113

1.15

0.16

1.1

1.3

0.0

1.2

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

102

0.85

0.16

2.3

2.6

—

(3011288) Drugs identified in Urine by Screen method

161

1202

0.96

0.16

4.2

2.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

117

0.86

0.16

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

393

0.93

0.16

1.1

—

(44813793)

118

885

0.96

0.15

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

657

0.95

0.15

1.2

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

131

0.88

0.14

1.2

1.5

67.9

38.1

—

(3016018) Differential panel - Cerebral spinal fluid

222

1643

0.97

0.14

1.5

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

358

1.07

0.14

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.83

0.14

9.7

8.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

288

2026

1.02

0.13

1.4

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

150

1.10

0.13

1.5

1.1

12.2

29.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

431

1.05

0.12

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

218

0.92

0.11

1.0

1.1

19.6

9.5

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

1.09

0.11

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.14

0.11

1.5

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

17659

127236

1.00

0.10

41.6

18.4

14.7

13.8

307.65

17297

124338

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.16

0.10

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

293

1.06

0.10

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

499

3636

0.99

0.09

1.8

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

350

1.05

0.09

1.5

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

118

1.10

0.09

1.2

1.1

1.0

0.6

u/ml

0.21

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.89

0.09

1.1

1.4

0.4

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

574

0.97

0.09

1.1

—

(3013762) Body weight Measured

1.08

0.09

1.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

200

1411

1.02

0.08

1.2

1.1

6.8

3.8

u/ml

0.72

481

(3026470) Cobalt [Mass/volume] in Blood

198

1453

0.98

0.08

1.8

2.0

4.3

3.7

ug/l

0.26

164

1280

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

163

0.93

0.08

2.0

1.9

14.3

18.4

umol/l

1.06

163

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.10

0.08

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.10

0.08

1.0

1.4

0.1

1.0

u/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

650

1.03

0.08

1.2

1.3

6.2

6.1

mmol/l

0.36

609

(3042517) Benzodiazepines panel - Urine

1.07

0.07

1.8

2.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

374

0.96

0.07

1.5

1.2

2.4

2.9

umol/l

0.67

337

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

374

0.96

0.07

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

155

1.07

0.07

1.0

1.1

—

(40758358) Immune stain study

0.86

0.07

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

127

1.08

0.06

1.1

1.4

0.1

nmol/l

0.01

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.12

0.06

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

871

6305

0.99

0.06

3.1

4.0

106.5

75.2

u/ml

1.00

836

6048

(3035933) Granulocytes/100 leukocytes in Blood

277

0.96

0.05

2.1

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

113

828

0.98

0.05

1.4

0.2

nmol/l

0.50

584

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

527

1.02

0.05

1.4

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

189

0.95

0.05

22.2

9.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

104

735

1.02

0.04

1.0

1.1

10.5

10.8

iu/ml

0.03

152

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

214

1.04

0.04

8.7

9.0

0.4

umol/l

0.08

196

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

264

1.04

0.04

2.2

2.0

32.4

7.2

ug/l

0.36

155

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

101

1.07

0.04

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

188

1.03

0.02

1.6

1.8

—

(3024316) Viscosity of Plasma

1.06

0.02

2.4

2.0

1.5

1.8

mpas

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.04

0.01

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

126

1.03

0.00

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

337

1.00

0.00

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.96

0.00

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

164

1.01

0.00

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

121

1.01

0.00

3.8

4.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

134

1.02

0.00

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

260

1.00

0.00

1.4

1.3

41.0

49.1

0.35

111

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

899

1.00

0.00

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.97

0.00

1.2

1.4

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

18.9

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

0.4

1.1

u/ml

—

(3022725) Serotonin [Moles/volume] in Serum

1.01

0.00

1.6

1.5

753.7

1114.7

nmol/l

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.2

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.88

0.00

1.2

2.0

1.9

mg/l

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.92

0.00

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HEARTFAIL and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL	1.872 [1.73, 2.02]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 93309 out of 148974 females with I9_HEARTFAIL died.

Males

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL	2.348 [2.15, 2.57]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 81980 out of 134565 males with I9_HEARTFAIL died.

Mortality risk

Mortality risk for people of age

years, who have I9_HEARTFAIL.

N-year risk	Females	Males
1	0.132%	0.369%
5	0.847%	2.109%
10	2.075%	5.33%
15	3.635%	9.966%
20	6.203%	16.023%

Relationships between endpoints

↥

Index endpoint: I9_HEARTFAIL – Heart failure, strict

GWS hits: 15

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Heart failure, strict

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints